Difference between revisions of "Circumcision and HIV"
WikiModEn2 (talk | contribs) m (→Problems with promoting circumcision as HIV prevention policy: spelling.) |
WikiModEn2 (talk | contribs) (→Philippines: Wikify.) |
||
(105 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | + | '''{{FULLPAGENAME}}''' discusses the relationship of male '''circumcision and HIV''' infection. For a discussion of [[circumcision]] and other sexually transmitted infections, see [[Circumcision and STDs]]. | |
− | Recently, circumcision has been heavily promoted as a method of preventing HIV. The [[World Health Organization|World Health Organization]] (WHO) | + | Recently, circumcision has been heavily promoted as a method of preventing [[HIV]]. The [[World Health Organization|World Health Organization]] (WHO), now known to be corrupted, hasitly endorsed male circumcision as a form of [[HIV]] prevention in 2007, based on three studies (2005) & (2007) conducted in Africa (Kenya, South Africa, and Uganda) which claim that male circumcision is supposed to "reduce the risk of [[HIV]] transmission by 60%."<ref>{{REFweb |
− | |||
|url=http://www.who.int/hiv/topics/malecircumcision/en/ | |url=http://www.who.int/hiv/topics/malecircumcision/en/ | ||
|title=Male circumcision for HIV prevention | |title=Male circumcision for HIV prevention | ||
− | |||
− | |||
|publisher=World Health Organization | |publisher=World Health Organization | ||
− | |||
|date=2007 | |date=2007 | ||
|accessdate=2011-05-06 | |accessdate=2011-05-06 | ||
Line 21: | Line 17: | ||
|date=2011-03-04 | |date=2011-03-04 | ||
|accessdate=2011-05-06 | |accessdate=2011-05-06 | ||
− | }}</ref> and the promotion of male circumcision as a HIV-prevention method by the [[Centers for Disease Control|Centers for Disease Control]]<ref>{{REFweb | + | }}</ref> and the promotion of male circumcision as a [[HIV]]-prevention method by the [[Centers for Disease Control|Centers for Disease Control]]<ref>{{REFweb |
|url=http://www.cdc.gov/hiv/resources/factsheets/circumcision.htm | |url=http://www.cdc.gov/hiv/resources/factsheets/circumcision.htm | ||
|title=Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States | |title=Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States | ||
− | |||
− | |||
|publisher= | |publisher= | ||
|date=2008-02 | |date=2008-02 | ||
Line 32: | Line 26: | ||
|url=http://www.cdc.gov/botusa/Success-Stories/0307-MaleCircumcision-Botswana.htm | |url=http://www.cdc.gov/botusa/Success-Stories/0307-MaleCircumcision-Botswana.htm | ||
|title=Success Stories: Male Circumcision: A Question and Answer Session | |title=Success Stories: Male Circumcision: A Question and Answer Session | ||
− | + | |publisher=[[CDC]] | |
− | |||
− | |publisher= | ||
|date=2007-03 | |date=2007-03 | ||
|accessdate=2011-06-01 | |accessdate=2011-06-01 | ||
Line 40: | Line 32: | ||
|url=http://www.cdcnpin.org/Display/FundDisplay.asp?FundNbr=4285 | |url=http://www.cdcnpin.org/Display/FundDisplay.asp?FundNbr=4285 | ||
|title=Funding | |title=Funding | ||
− | |||
− | |||
|publisher= | |publisher= | ||
|date=2011-01-09 | |date=2011-01-09 | ||
Line 49: | Line 39: | ||
== Origin of the circumcision/HIV hypothesis == | == Origin of the circumcision/HIV hypothesis == | ||
− | The idea that circumcision prevented HIV transmission was invented by Valiere Alcena, long before there was any "research" to substantiate the claim.<ref>{{REFjournal | + | The idea that [[circumcision]] prevented [[HIV]] transmission was invented by [[Valiere Alcena]], long before there was any "research" to substantiate the claim.<ref>{{REFjournal |
|last=Alcena | |last=Alcena | ||
|first=Valiere | |first=Valiere | ||
+ | |init=V | ||
+ | |author-link=Valiere Alcena | ||
|title=AIDS in Third World Countries | |title=AIDS in Third World Countries | ||
− | |journal= | + | |journal=N Y State J Med |
− | |volume= | + | |volume=8 |
− | + | |pages=446 | |
− | |pages= | + | |pubmedID=3463895 |
− | |||
− | |||
− | |pubmedID= | ||
− | |||
|DOI=10.1371/journal.pmed.0020298#r1326 | |DOI=10.1371/journal.pmed.0020298#r1326 | ||
|date=2006-10 | |date=2006-10 | ||
− | |accessdate= | + | |accessdate=2020-05-28 |
}}</ref> In 1986, California urologist [[Aaron J. Fink| Aaron J. Fink]], (1926-1994) adopted this idea,<ref>{{REFbook | }}</ref> In 1986, California urologist [[Aaron J. Fink| Aaron J. Fink]], (1926-1994) adopted this idea,<ref>{{REFbook | ||
|last=Glick | |last=Glick | ||
− | |first=Leonard | + | |first=Leonard B. |
+ | |init=LB | ||
|author-link=Leonard B. Glick | |author-link=Leonard B. Glick | ||
|year=2005 | |year=2005 | ||
Line 76: | Line 65: | ||
|chapter="This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy | |chapter="This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy | ||
|page=206 | |page=206 | ||
− | |location=New York, | + | |location=New York, NY |
− | |publisher=Oxford University Press | + | |publisher={{UNI|Oxford University|Oxon}} Press |
|isbn=0-19-517674-X | |isbn=0-19-517674-X | ||
|quote=What if circumcision protected against infection with HIV... | |quote=What if circumcision protected against infection with HIV... | ||
Line 85: | Line 74: | ||
|last=Weiss | |last=Weiss | ||
|first=Helen A. | |first=Helen A. | ||
+ | |init=HA | ||
+ | |author-link=Helen Weiss | ||
|last2=Quigley | |last2=Quigley | ||
|first2=Maria A. | |first2=Maria A. | ||
+ | |init2=MA | ||
|last3=Hayes | |last3=Hayes | ||
|first3=Richard J. | |first3=Richard J. | ||
+ | |init3=RJ | ||
|title=Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis | |title=Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis | ||
|journal=AIDS | |journal=AIDS | ||
Line 95: | Line 88: | ||
|pages=2361-2370 | |pages=2361-2370 | ||
|url=http://www.aidsonline.com/pt/re/aids/fulltext.00002030-200010200-00018.htm | |url=http://www.aidsonline.com/pt/re/aids/fulltext.00002030-200010200-00018.htm | ||
− | |||
|pubmedID=11089625 | |pubmedID=11089625 | ||
− | |||
|DOI=10.1097/00002030-200010200-00018 | |DOI=10.1097/00002030-200010200-00018 | ||
|date=2000-10 | |date=2000-10 | ||
− | |||
}}</ref> without any kind of proof whatsoever. | }}</ref> without any kind of proof whatsoever. | ||
− | In 1986, Fink sent a letter to the ''New England Journal of Medicine'' titled "A possible Explanation for Heterosexual Male Infection with AIDS," where he argued that the hard and toughened glans of the circumcised male resisted infection, while the soft and sensitive foreskin and glans mucosa of the intact male were ports of entry.<ref>{{REFjournal | + | In 1986, Fink sent a letter to the ''New England Journal of Medicine'' titled "A possible Explanation for Heterosexual Male Infection with [[AIDS]]," where he argued that the hard and toughened glans of the circumcised male resisted infection, while the soft and sensitive foreskin and glans [[mucosa]] of the intact male were ports of entry.<ref>{{REFjournal |
|last=Fink | |last=Fink | ||
|first=Aaron J. | |first=Aaron J. | ||
+ | |init=AJ | ||
+ | |author-link=Aaron J. Fink | ||
|title=A possible Explanation for Heterosexual Male Infection with AIDS | |title=A possible Explanation for Heterosexual Male Infection with AIDS | ||
|journal=New England Journal of Medicine | |journal=New England Journal of Medicine | ||
Line 112: | Line 104: | ||
|year=1986 | |year=1986 | ||
|page=1167 | |page=1167 | ||
− | }}</ref> Fink proposed in his letter: "I suspect that men in the United States, who, as compared with those in Africa and elsewhere, have had less acquisition of AIDS, have benefited from the high rate of newborn circumcision in the United States," regardless of the fact that the United States has one of the highest circumcision rates, and one of the highest HIV rates, in the western (industrialized) world (compare with European countries, Canda, and Australia).<ref>{{REFweb | + | |url=https://www.nejm.org/doi/full/10.1056/NEJM198610303151818 |
+ | |pubmedID=3762636 | ||
+ | |}}</ref> Fink proposed in his letter: "I suspect that men in the United States, who, as compared with those in Africa and elsewhere, have had less acquisition of [[AIDS]], have benefited from the high rate of newborn [[circumcision]] in the United States," regardless of the fact that the United States has one of the highest circumcision rates, and one of the highest [[HIV]] rates, in the western (industrialized) world (compare with European countries, Canda, and Australia).<ref>{{REFweb | ||
|url=http://www.who.int/hiv/facts/hiv2003/en/ | |url=http://www.who.int/hiv/facts/hiv2003/en/ | ||
|title=A global view of HIV infection | |title=A global view of HIV infection | ||
Line 124: | Line 118: | ||
Fink's proposal appeared in media throughout the US and Canada. Asked about his idea by a United Press reporter, Fink replied "This is nothing I can prove."<ref>{{REFbook | Fink's proposal appeared in media throughout the US and Canada. Asked about his idea by a United Press reporter, Fink replied "This is nothing I can prove."<ref>{{REFbook | ||
|last=Glick | |last=Glick | ||
− | |first=Leonard | + | |first=Leonard B. |
+ | |init=LB | ||
|author-link=Leonard B. Glick | |author-link=Leonard B. Glick | ||
|year=2005 | |year=2005 | ||
Line 134: | Line 129: | ||
|chapter="This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy | |chapter="This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy | ||
|page=207 | |page=207 | ||
− | |location=New York, | + | |location=New York, NY |
− | |publisher=Oxford University Press | + | |publisher={{UNI|Oxford University|Oxon}} Press |
|isbn=0-19-517674-X | |isbn=0-19-517674-X | ||
|quote=This is nothing I can prove. | |quote=This is nothing I can prove. | ||
|accessdate=2011-02-19 | |accessdate=2011-02-19 | ||
|note= | |note= | ||
− | }}</ref> This didn't stop other physicians from conducting "research" leading to a steady stream of widely publicized articles arguing that circumcised men were less likely to contract HIV | + | }}</ref> This didn't stop other physicians from conducting "research" leading to a steady stream of widely publicized articles arguing that circumcised men were less likely to contract [[HIV]] - with the result that prevention of [[HIV]] infection has now surpassed even cancer prevention as the most popular claim of circumcision advocates. |
{{Citation | {{Citation | ||
|Title=Fink's Own Words | |Title=Fink's Own Words | ||
|Text=This is nothing I can prove. | |Text=This is nothing I can prove. | ||
− | |Author=Aaron J. Fink | + | |Author=[[Aaron J. Fink]] |
|Source="This Little Operation". ''Marked in Your Flesh.'' p.206-208 | |Source="This Little Operation". ''Marked in Your Flesh.'' p.206-208 | ||
}} | }} | ||
− | Fink abandoned the circumcision/HIV controversy in 1991, and he died in 1994. He left behind an indelible legacy nonetheless; the circumcision/HIV hypothesis continues to be supported by researchers and scientists that are adopting his assertions and writing studies based upon them, and the campaign to establish a causal link between HIV infection and the presence of the foreskin continues to this day. | + | Alcena and Fink lacked a hypothesis to explain why the foreskin would be an entry point for HIV infection, but this was supplied by circumcision promoter [[Gerald N. Weiss]] and two colleagues. Weiss et al. (1993) produced the plausible but incorrect hypothesis that [[Langerhans cells]] attracted HIV. A medical journal in [[Israel]] was willing to publish the paper by Weiss et al.<ref name="weiss1993">{{REFjournal |
+ | |last=Weiss | ||
+ | |first=Gerald N. | ||
+ | |init=GN | ||
+ | |author-link=Gerald N. Weiss | ||
+ | |last2=Sanders | ||
+ | |first2= | ||
+ | |init2=M | ||
+ | |author2-link= | ||
+ | |last3=Westbrook | ||
+ | |first3= | ||
+ | |init3=KC | ||
+ | |author3-link= | ||
+ | |etal=no | ||
+ | |title=The distribution and density of Langerhans cells in the human prepuce: site of a diminished immune response? | ||
+ | |journal= Isr J Med Sci | ||
+ | |location= | ||
+ | |date=1993-01 | ||
+ | |volume=20 | ||
+ | |issue=1 | ||
+ | |article= | ||
+ | |page= | ||
+ | |pages=42-3 | ||
+ | |url= | ||
+ | |archived= | ||
+ | |quote= | ||
+ | |pubmedID=8454447 | ||
+ | |pubmedCID= | ||
+ | |DOI= | ||
+ | |accessdate=2022-10-28 | ||
+ | }}</ref>. | ||
+ | |||
+ | Fink abandoned the circumcision/[[HIV]] controversy in 1991, and he died in 1994. He left behind an indelible legacy nonetheless; the circumcision/[[HIV]] hypothesis continues to be supported by researchers and scientists that are adopting his assertions and writing studies based upon them, and the campaign to establish a causal link between [[HIV]] infection and the presence of the foreskin continues to this day. | ||
+ | |||
+ | ==Early research== | ||
+ | |||
+ | Hrdy (1987) identified numerous African cultural practices other than circumcision or non-circumcision that would contribute to the spread of [[HIV]] infection. Such factors include: | ||
+ | * Female circumcision and [[infibulation]]. | ||
+ | * Promiscuity. | ||
+ | * Homosexuality and anal intercourse. | ||
+ | * Practices resulting in exposure to blood. | ||
+ | * Practices involving the use of shared instruments. | ||
+ | * Contact with non-human primates.<ref name="hrdy1987">{{REFjournal | ||
+ | |last=Hrdy | ||
+ | |first=Danniel B | ||
+ | |init=DB | ||
+ | |etal=no | ||
+ | |title=Cultural practices contributing to the transmission of human immunodeficiency virus in Africa | ||
+ | |journal=Rev Infect Dis | ||
+ | |date=1987-11 | ||
+ | |volume=9 | ||
+ | |issue=6 | ||
+ | |pages=1109-19 | ||
+ | |url=http://www.cirp.org/library/disease/HIV/hrdy1/ | ||
+ | |pubmedID=3321361 | ||
+ | |DOI=10.1093/clinids/9.6.1109 | ||
+ | |accessdate=2021-05-12 | ||
+ | }}</ref> | ||
+ | |||
+ | Carael et al. (1988) studied [[HIV]] transmission among heterosexual couples in Central Africa. No difference was found between couples in which the male was circumcised and in which the male was intact.<ref name="carael1988">{{REFjournal | ||
+ | |last=Carael | ||
+ | |init=M | ||
+ | |author-link= | ||
+ | |last2=Van de Perre | ||
+ | |init2=PH | ||
+ | |author2-link= | ||
+ | |last3=LePage | ||
+ | |init3=PH | ||
+ | |author3-link= | ||
+ | |last4=Allen | ||
+ | |init4=S | ||
+ | |author4-link= | ||
+ | |etal=yes | ||
+ | |title=Human immunodeficiency virus transmission among heterosexual couples in Central Africa | ||
+ | |journal=AIDS | ||
+ | |location= | ||
+ | |date=1988-06 | ||
+ | |volume=2 | ||
+ | |issue=3 | ||
+ | |pages=201-5 | ||
+ | |url=http://www.cirp.org/library/disease/HIV/carael/ | ||
+ | |pubmedID=3134914 | ||
+ | |accessdate=2020-05-28 | ||
+ | }}</ref> | ||
+ | |||
+ | de Vincenzi & Mertens (1994) reviewed the literature regarding the alleged role of the [[foreskin]] in [[HIV]] transmission. They concluded: | ||
+ | <blockquote> | ||
+ | The potential public-health benefits of male circumcision have been greatly discussed in the past 50 years, often in a passionate and emotional manner. However, relatively few studies have been carried out and those that have, present conflicting results. The major criticism of most of the studies preformed to date is the lack of attention given to potential confounding factors, which could be related to both circumcision status and risk of sexually transmitted infections, such as sexual behaviour or differences in hygienic practices, or differential use of specific health facilities. As Poland [48] noted, "We must remember that circumcision is not performed randomly." | ||
+ | |||
+ | Therefore, further efforts are still required to quantify the relative risk associated with the lack of male circumcision. Some of this can be achieved by using observational designs which better address the limitations discussed above. Laboratory and primate research might also continue to provide useful information. | ||
+ | |||
+ | As the safety, expected benefits, feasibility and acceptability of mass circumcision are all questionable, neither public-health interventions nor intervention studies appear to be defensible options before there is stronger evidence from observational studies in different settings that show lack of male circumcision may be a genuinely independent risk factor for the transmission of [[HIV]].<ref>{{REFjournal | ||
+ | |last=de Vincenzi | ||
+ | |first=Isabelle | ||
+ | |init=I | ||
+ | |author-link= | ||
+ | |last2=Mertens | ||
+ | |first2=Thierry | ||
+ | |init2=T | ||
+ | |author2-link= | ||
+ | |etal=no | ||
+ | |title=Male circumcision: a role in HIV prevention? | ||
+ | |journal=AIDS | ||
+ | |date=1994 | ||
+ | |volume=8 | ||
+ | |issue=2 | ||
+ | |pages=153-60 | ||
+ | |url=http://www.cirp.org/library/disease/HIV/vincenzi/ | ||
+ | |pubmedID=8043224 | ||
+ | |accessdate=2020-05-29 | ||
+ | }}</ref> | ||
+ | </blockquote> | ||
+ | |||
+ | [[Robert Darby| Darby]] (2002) examined the claims that circumcision is preventive of infection with [[HIV]]. He tabulated the prevalence of circumcision and [[HIV]] infection in various nations. He found no connection between the prevalence of circumcision and [[HIV]] infection. Darby also compared the nineteenth century British attempts to control syphilis (then a dreaded and incurable disease) with male circumcision, which was equally unsuccessful.<ref name="darby2002">{{REFjournal | ||
+ | |last=Darby | ||
+ | |first=Robert | ||
+ | |init=R | ||
+ | |author-link=Robert Darby | ||
+ | |url=https://pool.intactiwiki.org/w/images/2002-09_Darby-BeenThereDoneThat.pdf | ||
+ | |title=Been There, Done That: Thoughts on the proposition that yet more circumcision can save the world from AIDS | ||
+ | |journal=Australian Quarterly | ||
+ | |date=2002-09 | ||
+ | |volume=74 | ||
+ | |issue=5 | ||
+ | |pages=26-35 | ||
+ | |accessdate=2021-05-08 | ||
+ | }} | ||
+ | </ref> | ||
+ | |||
+ | Thomas et al. (2004) studied the incidence of [[HIV]] in [[circumcised]] and [[intact]] men in a United States Navy population. A slightly higher incidence of [[HIV]] infection was found in circumcised men (84.9%) as compared with intact men (81.8%). The authors concluded: | ||
+ | <blockquote> | ||
+ | Although there may be other medical or cultural reasons for male circumcision, it is not associated with [[HIV]] or STI prevention in this U.S. military population.<ref name="thomas2004">Thomas AG, Bakhireva LN, Brodine SK, Shaffer RA. [http://www.cirp.org/library/disease/HIV/thomas1/ Prevalence of male circumcision and its association with HIV and sexually transmitted infections in a U.S. Navy population]. Abstract no. TuPeC4861. Presented at the XV International [[AIDS]] Conference, Bangkok, Thailand, July 11-16, 2004.</ref> | ||
+ | </blockquote> | ||
== Confounding factors == | == Confounding factors == | ||
Line 154: | Line 281: | ||
=== Debunked ad-hoc hypotheses === | === Debunked ad-hoc hypotheses === | ||
− | Various hypotheses have been suggested in regards to the mechanism whereby circumcision prevents the tarnsmission of HIV. They have all been disproven, however, and all of the "studies" attempting to establish a causal link between circumcion and HIV transmission remain unsubstantiated by a working hypothesis. | + | Various hypotheses have been suggested in regards to the mechanism whereby circumcision prevents the tarnsmission of [[HIV]]. They have all been disproven, however, and all of the "studies" attempting to establish a causal link between circumcion and [[HIV]] transmission remain unsubstantiated by a working hypothesis. |
− | ==== | + | ==== Keratinization hypothesis ==== |
− | Perhaps the oldest hypothesis on the mechanism whereby circumcision prevents the transmission of HIV is the theory that suggests that the keratinized surface of the penis in circumcised male resists infection, while the mucosa of the glans and inner of the intact male are ports of entry, which was purported by [[Aaron J. Fink]]. | + | Perhaps the oldest hypothesis on the mechanism whereby circumcision prevents the transmission of [[HIV]] is the theory that suggests that the [[Keratinization| keratinized]] surface of the penis in circumcised male resists infection, while the [[mucosa]] of the glans and inner of the intact male are ports of entry, which was purported by [[Aaron J. Fink]]. |
− | Recent studies, however, disprove this hypothesis. One study found that there is "no difference between the keratinization of the inner and outer aspects of the adult male foreskin," and that "keratin layers alone were unlikely to explain why uncircumcised men are at higher risk for HIV infection."<ref>{{REFjournal | + | Recent studies, however, disprove this hypothesis. One study found that there is "no difference between the keratinization of the inner and outer aspects of the adult male foreskin," and that "keratin layers alone were unlikely to explain why [[uncircumcised]] men are at higher risk for [[HIV]] infection."<ref>{{REFjournal |
|last=Dinh | |last=Dinh | ||
− | | | + | |init=MH |
|last2=McRaven | |last2=McRaven | ||
− | | | + | |init2=MD |
|last3=Kelley | |last3=Kelley | ||
− | | | + | |init3=Z |
|last4=Penugonda | |last4=Penugonda | ||
− | | | + | |init4=S |
|last5=Hope | |last5=Hope | ||
− | | | + | |init5=TJ |
|title=Keratinization of the adult male foreskin and implications for male circumcision | |title=Keratinization of the adult male foreskin and implications for male circumcision | ||
|journal=AIDS | |journal=AIDS | ||
Line 176: | Line 303: | ||
|pages=899-906 | |pages=899-906 | ||
|url=http://www.ncbi.nlm.nih.gov/pubmed/20098294 | |url=http://www.ncbi.nlm.nih.gov/pubmed/20098294 | ||
− | |quote=We found no difference between the keratinization of the inner and outer aspects of the adult male foreskin. Keratin layers alone are unlikely to explain why uncircumcised men are at higher risk for HIV infection. | + | |quote=We found no difference between the keratinization of the inner and outer aspects of the adult male foreskin. Keratin layers alone are unlikely to explain why [[uncircumcised]] men are at higher risk for HIV infection. |
|pubmedID=20098294 | |pubmedID=20098294 | ||
|pubmedCID= | |pubmedCID= | ||
Line 196: | Line 323: | ||
==== Langerhans cell hypothesis ==== | ==== Langerhans cell hypothesis ==== | ||
− | Recent circumcision studies in Africa were conducted under the hypothesis that the [[Langerhans cells]] were the prime port of entry for the HIV virus. According to the hypothesis, circumcision was supposed to prevent HIV transmission by removing the Langerhans cells found in the inner | + | Recent circumcision studies in Africa were conducted under the hypothesis that the [[Langerhans cells]] were the prime port of entry for the [[HIV]] virus. According to the hypothesis, circumcision was supposed to prevent [[HIV]] transmission by removing the Langerhans cells found in the inner [[mucosa]]l lining of the foreskin. |
− | deWitte found that not only are Langerhans cells found all over the body and that their complete removal is virtually impossible | + | deWitte found that not only are Langerhans cells found all over the body and that their complete removal is virtually impossible, but furthermore, deWitte found that Langerhans cells that are present in the [[foreskin]] produce ''Langerin'', a substance that has been proven to kill the [[HIV]] virus on contact, acting as a natural barrier to HIV-1 transmission by Langerhans cells.<ref>{{DeWitte etal 2007}}</ref> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | }}</ref> | ||
==== Bacterial environment hypothesis ==== | ==== Bacterial environment hypothesis ==== | ||
− | This hypothesis attempts to identify the change in bacterial environment that results in the penis as a result of circumcision, as the mechanism whereby circumcision reduces the spread of HIV transmission. A | + | This hypothesis attempts to identify the change in [[microbiome| bacterial environment]] that results in the [[penis]] as a result of [[adult circumcision]], as the mechanism whereby circumcision reduces the spread of [[HIV]] transmission. A desperate ad-hoc hypothesis, the explanation is rather farfetched. The argument is that the change in bacterial environment after circumcision makes it difficult for bacteria that cause diseases to live; there are less chances for penile inflammation, a condition that facilitates the transmission of viruses. The chances for penile inflammation are reduced, thereby reducing the chances of sexually transmitted viruses, such as [[HIV]].<ref>{{REFjournal |
|last=Price | |last=Price | ||
|first=Lance B. | |first=Lance B. | ||
+ | |init=LB | ||
+ | |last2=Liu | ||
|first2=Cindy M. | |first2=Cindy M. | ||
− | | | + | |init2=CM |
− | |||
|last3=Johnson | |last3=Johnson | ||
− | | | + | |first3=Kristine E. |
+ | |init3=KE | ||
|last4=Aziz | |last4=Aziz | ||
− | | | + | |first4=Maliha |
+ | |init4=M | ||
|last5=Lau | |last5=Lau | ||
− | | | + | |first5=Matthew K. |
+ | |init5=MK | ||
|last6=Bowers | |last6=Bowers | ||
− | | | + | |first6=Jolene |
+ | |init6=J | ||
|last7=Ravel | |last7=Ravel | ||
− | | | + | |first7=Jacques |
+ | |init7=J | ||
|last8=Keim | |last8=Keim | ||
− | | | + | |first8=Paul S. |
+ | |init8=PS | ||
|last9=Serwadda | |last9=Serwadda | ||
− | | | + | |first9=David |
+ | |init9=D | ||
|last10=Wawer | |last10=Wawer | ||
− | | | + | |first10=Maria J. |
+ | |init10=MJ | ||
|last11=Gray | |last11=Gray | ||
+ | |first11=Ronald H. | ||
+ | |init11=RH | ||
|etal=yes | |etal=yes | ||
|title=The Effects of Circumcision on the Penis Microbiome | |title=The Effects of Circumcision on the Penis Microbiome | ||
Line 260: | Line 367: | ||
|volume=5 | |volume=5 | ||
|issue=1 | |issue=1 | ||
− | + | |url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008422 | |
− | |url= | ||
|quote=The anoxic microenvironment of the subpreputial space may support pro-inflammatory anaerobes that can activate Langerhans cells to present HIV to CD4 cells in draining lymph nodes. Thus, the reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases. | |quote=The anoxic microenvironment of the subpreputial space may support pro-inflammatory anaerobes that can activate Langerhans cells to present HIV to CD4 cells in draining lymph nodes. Thus, the reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases. | ||
− | |||
− | |||
|DOI=10.1371/journal.pone.0008422 | |DOI=10.1371/journal.pone.0008422 | ||
|date=2010 | |date=2010 | ||
Line 270: | Line 374: | ||
}}</ref> | }}</ref> | ||
− | Presenting this hypothesis presents a two-fold problem. First, it presents an irrelevant conclusion; the randomized control trials were measuring frequency in HIV transmission, not for frequency in penile bacterial | + | Presenting this hypothesis presents a two-fold problem. First, it presents an irrelevant conclusion; the discredited randomized control trials were measuring frequency in [[HIV]] transmission, not for frequency in penile bacterial inflammation, and whether said inflammation facilitated sexually transmitted [[HIV]]. And secondly, circumcision advocates give themselves the new burden of proving the newly introduced hypothesis, that change in bacterial infection does indeed result in a significant reduction of [[HIV]] transmission. A new study is needed to measure [[HIV]] transmission in men who have been [[circumcised]], [[intact]] men with constant penile inflammations, and [[intact]] men who don't suffer constant penile inflammation. Unless the randomized controlled studies were limited to only [[intact]] men who suffered constant penile inflammation. |
+ | |||
+ | == The immunological function of the foreskin == | ||
+ | |||
+ | The [[foreskin]]'s inner fold and the [[glans]] of the penis are comprised of [[Preputial mucosa|mucous membrane]] tissue. These are also present in your eyes, mouth, and all other bodily orifices including the female genitals. These are the first line of immunological defense for the body's orifices. These mucous membranes perform many immunological and hygienic functions. | ||
+ | |||
+ | Certain components such as [[Langerhans cells]],<ref>{{REFjournal | ||
+ | |last=Weiss | ||
+ | |init=GN | ||
+ | |last2=Sanders | ||
+ | |init2=M | ||
+ | |last3=Westbrook | ||
+ | |init3=KC | ||
+ | |url=http://www.circumstitions.com/Langerhans.html | ||
+ | |title=The distribution and density of Langerhans cells in the human prepuce: site of diminished immune response? | ||
+ | |journal=Isr J Med Sci | ||
+ | |date=1993-01 | ||
+ | |volume=29 | ||
+ | |issue=1 | ||
+ | |pages=42-43 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> plasma cells,<ref name="flower1983">{{REFjournal | ||
+ | |last=Flower | ||
+ | |init=PJ | ||
+ | |last2=Ladds | ||
+ | |init2=PW | ||
+ | |last3=Thomas | ||
+ | |init3=AD | ||
+ | |last4=Watson | ||
+ | |init4=DL | ||
+ | |url=https://journals.sagepub.com/doi/abs/10.1177/030098588302000206 | ||
+ | |title=An immunopathologic study on the bovine prepuce | ||
+ | |journal=Vet Pathol | ||
+ | |date=1983-03 | ||
+ | |volume=20 | ||
+ | |issue=2 | ||
+ | |pages=189-201 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> apocrine glands,<ref>{{REFjournal | ||
+ | |last=Ahmed | ||
+ | |init=A | ||
+ | |last2=Jones | ||
+ | |init2=AW | ||
+ | |url=https://www.academia.edu/5687437/APOCRINE_CYSTADENOMA_A_REPORT_OF_TWO_CASES_OCCURRING_ON_THE_PREPUCE | ||
+ | |title=Apocrine Cystadenoma: a report of two cases occurring on the prepuce | ||
+ | |journal=Br J Dermatol | ||
+ | |date=1969-12 | ||
+ | |volume=81 | ||
+ | |issue=12 | ||
+ | |pages=899-901 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> and sebaceous glands,<ref>{{REFjournal | ||
+ | |last=Hyman | ||
+ | |init=AB | ||
+ | |last2=Brownstein | ||
+ | |init2=MH | ||
+ | |title=Tyson's "glands": ectopic sebaceous glands and papillomatosis penis | ||
+ | |journal=Arch Dermatol | ||
+ | |date=1969-01 | ||
+ | |volume=99 | ||
+ | |issue=1 | ||
+ | |pages=31-36 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Delbanco | ||
+ | |init=E | ||
+ | |title=Über das gehäufte Auftreten von freien Talgdrüsen an der Innenfläche des Präputiums | ||
+ | |trans-title=About the increased occurrence of free sebaceous glands on the inner surface of the prepuce | ||
+ | |language=German | ||
+ | |journal=Monatshefte für praktische Dermatologie | ||
+ | |date=1904 | ||
+ | |volume=38 | ||
+ | |pages=536-538 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Piccinno | ||
+ | |init=R | ||
+ | |last2=Carrel | ||
+ | |first2=Ch.-F. | ||
+ | |init2=CF | ||
+ | |last3=Menni | ||
+ | |init3=S | ||
+ | |etal=yes | ||
+ | |title=sebacous glands mimicking molluscum contagiosum | ||
+ | |journal=Acta Derm Venerol | ||
+ | |date=1990 | ||
+ | |volume=70 | ||
+ | |pages=344-345 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Krompecher | ||
+ | |first=St. | ||
+ | |init=S | ||
+ | |title=Die Histologie der Absonderung des Smegma praeputii | ||
+ | |trans-title=Histology of allocation of a smegma praeputii | ||
+ | |language=German | ||
+ | |journal=Anatomischer Anzeiger | ||
+ | |date=1932 | ||
+ | |volume=75 | ||
+ | |pages=170-176 | ||
+ | }}</ref>, collectively secrete emollient lubricants.<ref name="parkash-jeykumar1973">{{REFjournal | ||
+ | |last=Parkash | ||
+ | |init=S | ||
+ | |last2=Jeykumar | ||
+ | |init2=S | ||
+ | |last3=Subramanyan | ||
+ | |init3=K | ||
+ | |last4=Chaudhuri | ||
+ | |init4=S | ||
+ | |url=http://www.cirp.org/library/anatomy/parkash/ | ||
+ | |title=Human subpreputial collection: its nature and formation | ||
+ | |journal=J Urol | ||
+ | |date=1973-08 | ||
+ | |volume=110 | ||
+ | |issue=2 | ||
+ | |pages=211-212 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> Apocrine glands perform a crucial function by secreting enzymes such as lysosomal enzymes, cathepsin B, chymotrypsin, and neutrophil elastase.<ref>{{REFjournal | ||
+ | |last=Frohlich | ||
+ | |init=E | ||
+ | |last2=Shamburg-Lever | ||
+ | |init2=G | ||
+ | |last3=Klesses | ||
+ | |init3=C | ||
+ | |title=Immunelectron microscopic localization of cathepsin B in human apocrine glands | ||
+ | |journal=J Cutan Pathol | ||
+ | |date=1993-02 | ||
+ | |volume=20 | ||
+ | |issue=1 | ||
+ | |pages=54-60 | ||
+ | }}</ref> | ||
+ | |||
+ | There is also some research to suggest that lysozyme may protect against HIV infection.<ref>{{REFweb | ||
+ | |first=George | ||
+ | |last=Hill | ||
+ | |author-link=George Hill | ||
+ | |url=http://www.cirp.org/library/disease/HIV/hill1/ | ||
+ | |title=Summary of evidence that the foreskin and lysozyme may protect against HIV infection | ||
+ | |date=2003-09-07 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> <ref name="fleiss-hodges-vanhowe1998" /> | ||
− | === | + | Apocrine glands also produce cytokine,<ref>{{REFjournal |
+ | |last=Ahmed | ||
+ | |init=AA | ||
+ | |last2=Nordlind | ||
+ | |init2=K | ||
+ | |last3=Schultzberd | ||
+ | |init3=M | ||
+ | |last4=Liden | ||
+ | |init4=S | ||
+ | |url=https://link.springer.com/article/10.1007%2FBF01105803 | ||
+ | |title=Immunohistochemical localization of IL-1 alpha-, IL-1 beta-, IL-6- and TNF-alpha-like immunoreactivities in human apocrine glands | ||
+ | |journal=Arch Dermatol Res | ||
+ | |date=1995 | ||
+ | |volume=287 | ||
+ | |issue=8 | ||
+ | |pages=764-766 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> which is a very important non-antibody protein that generates immune response when in contact with specific agents. Plasma cells which increase in number in response to pathogens levels, secrete immunoglobulin.<ref name="flower1983"/> | ||
+ | It is also very important to note that [[Langerhans cells]] that are present in the foreskin produce ''Langerin'', a substance that has been proven to kill human immunodeficency virus ([[HIV]]) on contact.<ref>{{REFjournal | ||
+ | |last=de Witte | ||
+ | |init=L | ||
+ | |last2=Nabatov | ||
+ | |init2=A | ||
+ | |last3=Pion | ||
+ | |init3=M | ||
+ | |etal=yes | ||
+ | |url=http://www.cirp.org/news/healthday2007-03-05/ | ||
+ | |title=Langerin is a natural barrier to HIV-1 transmission by Langerhans cells | ||
+ | |journal=Nat Med | ||
+ | |date=2007-03 | ||
+ | |volume=13 | ||
+ | |issue=3 | ||
+ | |pages=367-371 | ||
+ | |accessdate=2019-10-20 | ||
+ | }}</ref> | ||
− | + | All of these function to sequester and “digest” foreign pathogens. All these substances play an important role in protecting the [[penis]] from viral and bacterial pathogens. The immunological functions of the human [[prepuce]] have been extensively documented by respected researchers for quite some time.<ref name="fleiss-hodges-vanhowe1998">{{FleissP HodgesF VanHoweRS 1998}}</ref> | |
− | + | Circumcision destroys the natural [[Immunological and protective function of the foreskin| immunological protections of the foreskin]] and [[preputial sac]], so it results in increased risk of contracting [[infection]]. | |
− | ===== Cameroon | + | == African RCTs == |
− | In Cameroon, where 91% of the male population is circumcised, the ratio of circumcised men vs. intact men who contracted HIV was 4.1 vs. 1.1. <ref>{{REFbook | + | Strong bias exists in the RCTs.<ref>{{REFjournal |
+ | |last=Green | ||
+ | |init=LW | ||
+ | |etal=yes | ||
+ | |title=Male circumcision is not the HIV 'vaccine' we have been waiting for! | ||
+ | |url=https://www.arclaw.org/wp-content/uploads/Green-Circumcision-not-HIV-Vaccine-2008.pdf | ||
+ | |format=PDF | ||
+ | |journal=Future HIV Ther | ||
+ | |date=2008 | ||
+ | |volume=2 | ||
+ | |issue=3 | ||
+ | |pages=193–199 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Montori | ||
+ | |init=VM | ||
+ | |last2=Devereaux | ||
+ | |init2=PJ | ||
+ | |last3=Adhikari | ||
+ | |init3=NKJ | ||
+ | |etal=yes | ||
+ | |title=Randomized trials stopped early for benefit: a systematic review | ||
+ | |url=https://d1wqtxts1xzle7.cloudfront.net/57167251/Randomized_Trials_Stopped_Early_for_Bene20180810-22454-13zq2zz.pdf?1533940688=&response-content-disposition=inline%3B+filename%3DRandomized_Trials_Stopped_Early_for_Bene.pdf&Expires=1615121597&Signature=JYjNyliXY07z-v1JvMYVTVJG9IXinNjHYEsmuOy5GWAvqugfhsIwpf~gDfqgLbvyVwGpOQ-6~k05ckod-TeM~zo7Ja-fy1p-mg027mlh~MxWCjgQXWVFenwNqHV6liaq~8fVHQ5aZNRkQnu170vW4faves-pNadzVaRo0CgAtr2dvzQ4hA8dXYHKEuMXMyAsOTjErY-1Zgurz2mGdn99oya4~yAnUkj6QiYgVeDKiLJCTxRB6arwHJrIYDwcCh6vzkqZx7e23Faiiv6pXrB-plS1neoUQp5gE1UVt40YUiqpAlkAYmcxmsTJ~pPmZoIgRPLGcqN0rqpjPjlHwhycFw__&Key-Pair-Id=APKAJLOHF5GGSLRBV4ZA | ||
+ | |journal=JAMA | ||
+ | |date=2005 | ||
+ | |volume=294 | ||
+ | |pages=2203-2209 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Ioannidis | ||
+ | |init=JP | ||
+ | |title=Contradicted and initially stronger effects in highly cited clinical research | ||
+ | |url=https://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.321.8200&rep=rep1&type=pdf | ||
+ | |format=PDF | ||
+ | |journal=JAMA | ||
+ | |date=2005 | ||
+ | |volume=294 | ||
+ | |pages=218-228 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Wheatley | ||
+ | |init=K | ||
+ | |last2=Clayton | ||
+ | |init2=D | ||
+ | |title=Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML12 randomization | ||
+ | |url=https://www.sciencedirect.com/science/article/abs/pii/S0197245602002738 | ||
+ | |journal=Control Clin Trials | ||
+ | |date=2003 | ||
+ | |volume=24 | ||
+ | |pages=66-70 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Slutsky | ||
+ | |init=AS | ||
+ | |last2=Lavery | ||
+ | |init2=JV | ||
+ | |title=Data safety and monitoring boards | ||
+ | |journal=N Engl J Med | ||
+ | |date=2004 | ||
+ | |volume=350 | ||
+ | |pages=1143-1147 | ||
+ | }}</ref> "These trials, designed to detect a minimum 50 percent reduction in [[HIV]] risk, should provide definitive evidence regarding the efficacy and safety of MC within three to five years."<ref>{{REFdocument | ||
+ | |contribution=Male Circumcision: Current Epidemiological and Field Evidence | ||
+ | |quote=designed to detect a minimum 50 percent reduction in HIV risk | ||
+ | |url=https://path.azureedge.net/media/documents/HIV-AIDS_male-circ.pdf | ||
+ | |title=Program and Policy Implications For HIV Prevention and Reproductive Health | ||
+ | |publisher=USAID | ||
+ | |format=PDF | ||
+ | |date=2002-01 | ||
+ | |accessdate=2019-09-29 | ||
+ | }}</ref> By designing a trial to "detect" a minimum 50 percent reduction risk in [[HIV]], these researchers might have artificially created the clinical setting to observe the effect they were looking to discover. | ||
+ | |||
+ | Boyle & Hill (2011) have shown these RCTs to be have significant methodological flaws and statistical errors that render their claims invalid. Although a 60 percent ''relative'' reduction in [[HIV]] was claimed, the ''absolute'' reduction was a statistically insignificant 1.3 percent.<ref name="boyle-hill2011">{{BoyleGJ HillG 2011}}</ref> | ||
+ | |||
+ | Concerns about the [[HIV trials in Africa|three randomized controlled clinical trials (RCCTs) in Africa]] (in South Africa, Uganda, and Kenya)<ref>{{RCT Auvert et al 2005}}</ref><ref name="bailey2007">{{RCT Bailey et al 2007}}</ref><ref name="gray2007">{{RCT Gray et al 2007}}</ref>: | ||
+ | * The three RCTs were terminated early because results had reached a signifıcent level showing reduced [[HIV]] infections in experimental compared with control groups; however, it was too soon to gauge long-term effectiveness. | ||
+ | * The results have no relevance for women or for men who have sex with men. | ||
+ | * Far more participants were lost to follow-up than were reported to have contracted [[HIV]]. | ||
+ | * A substantial number of participants appeared to have contracted [[HIV]] from nonsexual sources: 23 of the 69 infections reported in the South African trial and 16 of the 67 in the Ugandan study.<ref>{{REFbook | ||
+ | |last=Gisselquist | ||
+ | |first=D. | ||
+ | |init=D | ||
+ | |year=2008 | ||
+ | |title=Points to consider: responses to HIV/AIDS in Africa, Asia, and the Caribbean | ||
+ | |url= | ||
+ | |publisher=Adonis and Abbey | ||
+ | |location=London | ||
+ | |pages= | ||
+ | |chapter=7 | ||
+ | |isbn= | ||
+ | |accessdate= | ||
+ | }}</ref> | ||
+ | * Participants received continuous counseling, free condoms, and monitoring for infection, which was unlikely in real-world campaigns. | ||
+ | * The sanitary conditions of the surgeries would be diffıcult to replicate on a mass scale in many parts of Africa where [[HIV]] infection rates and prevalence are highest.<ref>{{REFjournal | ||
+ | |last=Weiss | ||
+ | |init=HA | ||
+ | |last2=Quigley | ||
+ | |init2=MA | ||
+ | |last3=Hayes | ||
+ | |init3=RJ | ||
+ | |title=Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis | ||
+ | |journal=AIDS | ||
+ | |date=2000 | ||
+ | |volume=14 | ||
+ | |pages=2361–2370 | ||
+ | }}</ref><ref>{{REFjournal | ||
+ | |last=Siegfried | ||
+ | |init=N | ||
+ | |last2=Muller | ||
+ | |init2=M | ||
+ | |last3=Deeks | ||
+ | |init3=J | ||
+ | |etal=yes | ||
+ | |title=HIV and male circumcision — a systematic review with assessment of the quality of studies | ||
+ | |journal=Lancet Infect Dis | ||
+ | |date=2005 | ||
+ | |volume=5 | ||
+ | |pages=165–173 | ||
+ | }}</ref> | ||
+ | * Follow-up of any of these RCCTs is impossible. Study participants agreed to be circumcised when joining the study and were randomized into “circumcise now” and “circumcise later” groups.<ref>{{REFjournal | ||
+ | |last=Slutsky | ||
+ | |init=AS | ||
+ | |last2=Lavery | ||
+ | |init2=JV | ||
+ | |title=Data safety and monitoring boards | ||
+ | |journal=N Engl J Med | ||
+ | |date=2004 | ||
+ | |volume=350 | ||
+ | |pages=1143-1147 | ||
+ | }}</ref> | ||
+ | |||
+ | == Real world data == | ||
+ | |||
+ | === Countries in Africa === | ||
+ | |||
+ | According to demographic health studies performed in other countries in Africa, [[HIV]] transmission was prevalent in [[circumcised]] men in at least 6 different countries: | ||
+ | |||
+ | ==== Cameroon ==== | ||
+ | In Cameroon, where 91% of the male population is circumcised, the ratio of [[circumcised[[ men vs. [[intact]] men who contracted [[HIV]] was 4.1 vs. 1.1. <ref>{{REFbook | ||
|last=Mosoko | |last=Mosoko | ||
|first=Jembia J. | |first=Jembia J. | ||
+ | |init=JJ | ||
|last2=Affana | |last2=Affana | ||
|first2=Gislaine A. N. | |first2=Gislaine A. N. | ||
+ | |init2=GAN | ||
|year=2005 | |year=2005 | ||
|title=Prévalence du VIH et facteurs associés | |title=Prévalence du VIH et facteurs associés | ||
Line 300: | Line 713: | ||
}}</ref> | }}</ref> | ||
− | + | ==== Ghana ==== | |
− | In Ghana, the ratio is 1.6 vs 1.4 (95.3% circumcised). ''"...the vast majority of Ghanaian men (95 percent) are circumcised... There is little difference in the HIV prevalence by circumcision status..."''<ref>{{REFbook | + | In Ghana, the ratio is 1.6 vs 1.4 (95.3% circumcised). ''"...the vast majority of Ghanaian men (95 percent) are circumcised... There is little difference in the [[HIV]] prevalence by circumcision status..."''<ref>{{REFbook |
|last=Marum | |last=Marum | ||
|first=L. | |first=L. | ||
+ | |init=L | ||
|last2=Muttunga | |last2=Muttunga | ||
|first2=J. | |first2=J. | ||
+ | |init2=J | ||
|last3=Munene | |last3=Munene | ||
|first3=F. | |first3=F. | ||
+ | |init3=F | ||
|year=Central Bureau of Statistics | |year=Central Bureau of Statistics | ||
|title=HIV Prevalence and Associated Factors | |title=HIV Prevalence and Associated Factors | ||
Line 325: | Line 741: | ||
}}</ref> | }}</ref> | ||
− | + | ==== Lesotho ==== | |
In Lesotho, the ratio is 22.8 vs 15.2 (23% circumcised). | In Lesotho, the ratio is 22.8 vs 15.2 (23% circumcised). | ||
− | ''"The relationship between male circumcision and HIV levels in Lesotho does not conform to the expected pattern of higher rates among uncircumcised men than circumcised men. The HIV rate is in fact substantially higher among circumcised men (23 percent) than among men who are not circumcised (15 percent). Moreover, the pattern of higher infection rates among circumcised men compared with uncircumcised men is virtually uniform across the various subgroups for which results are shown in | + | ''"The relationship between male circumcision and [[HIV]] levels in Lesotho does not conform to the expected pattern of higher rates among [[uncircumcised]] men than circumcised men. The [[HIV]] rate is in fact substantially higher among circumcised men (23 percent) than among men who are not circumcised (15 percent). Moreover, the pattern of higher infection rates among circumcised men compared with [[uncircumcised]] men is virtually uniform across the various subgroups for which results are shown in the table. This finding could be explained by the Lesotho custom to conduct male circumcision later in life, when the individuals have already been exposed to the risk of [[HIV]] infection. (Additional analysis is necessary to better understand the unexpected pattern in Table 12.9.)"''<ref>{{REFbook |
|last= | |last= | ||
|first= | |first= | ||
Line 347: | Line 763: | ||
}}</ref> | }}</ref> | ||
− | ::''An interesting defense of male circumcision, given the fact that the latest "studies," if they can even be called that, observed HIV transmission in men circumcised as adults. Then again, this demographic health survey was conducted in 2004, BEFORE the newer "studies" in 2006. None the less, the unproven assertion that "circumcision is only effective in reducing the risk of HIV when done in infancy" persists in some circles.'' | + | ::''An interesting defense of male circumcision, given the fact that the latest "studies," if they can even be called that, observed [[HIV]] transmission in men [[circumcised]] as adults. Then again, this demographic health survey was conducted in 2004, BEFORE the newer "studies" in 2006. None the less, the unproven assertion that "circumcision is only effective in reducing the risk of [[HIV]] when done in infancy" persists in some circles.'' |
− | + | ==== Malawi ==== | |
DHS 2004 - 13.2 vs 9.5 (20% circumcised) | DHS 2004 - 13.2 vs 9.5 (20% circumcised) | ||
− | :"The relationship between HIV prevalence and circumcision status is not in the expected | + | :"The relationship between [[HIV]] prevalence and circumcision status is not in the expected |
− | direction. In Malawi, circumcised men have a slightly higher HIV infection rate than men who were | + | direction. In Malawi, circumcised men have a slightly higher [[HIV]] infection rate than men who were |
not circumcised (13 percent compared with 10 percent). In Malawi, the majority of men are not | not circumcised (13 percent compared with 10 percent). In Malawi, the majority of men are not | ||
circumcised (80 percent).<ref>{{REFbook | circumcised (80 percent).<ref>{{REFbook | ||
|last=Chipeta | |last=Chipeta | ||
|first=John | |first=John | ||
+ | |init=J | ||
|last2=Schouten | |last2=Schouten | ||
|first2=Erik | |first2=Erik | ||
+ | |init2=E | ||
|last3=Aberle-Grasse | |last3=Aberle-Grasse | ||
|first3=John | |first3=John | ||
+ | |init3=J | ||
|year=2005 | |year=2005 | ||
|title=HIV Prevalence and Associated Factors | |title=HIV Prevalence and Associated Factors | ||
Line 377: | Line 796: | ||
|note= | |note= | ||
}}</ref> | }}</ref> | ||
− | ::''...where one would expect HIV to be the most rampant.'' | + | ::''...where one would expect [[HIV]] to be the most rampant.'' |
− | + | ==== Rwanda ==== | |
DHS 2005 - 3.8 vs 2.1 <ref>http://www.measuredhs.com/pubs/pdf/FR183/15Chapter15.pdf p. 10</ref> | DHS 2005 - 3.8 vs 2.1 <ref>http://www.measuredhs.com/pubs/pdf/FR183/15Chapter15.pdf p. 10</ref> | ||
− | + | ====South Africa==== | |
− | + | Rosenberg et al. (2018) report that circumcised men in South Africa are more likely to be [[HIV]] infected than intact men.<ref name="Rosenberg2018">{{REFjournal | |
− | Rosenberg | ||
|last=Rosenberg | |last=Rosenberg | ||
|first=Molly S. | |first=Molly S. | ||
+ | |init=MS | ||
|author-link= | |author-link= | ||
|last2=Gómez-Olivé | |last2=Gómez-Olivé | ||
− | | | + | |init2=FX |
|author2-link= | |author2-link= | ||
|last3=Ronr | |last3=Ronr | ||
− | |first3=Julia K | + | |first3=Julia K. |
+ | |init3=JK | ||
|author3-link= | |author3-link= | ||
|last4=Kahn | |last4=Kahn | ||
|first4=Kathleen | |first4=Kathleen | ||
+ | |init4=K | ||
|author4-link= | |author4-link= | ||
|last5=Bärnighausen | |last5=Bärnighausen | ||
− | |first5=Till W | + | |first5=Till W. |
+ | |init5=TW | ||
|author5-link= | |author5-link= | ||
|etal=no | |etal=no | ||
|title=Are circumcised men safer sex partners? Findings from the HAALSI cohort in rural South Africa | |title=Are circumcised men safer sex partners? Findings from the HAALSI cohort in rural South Africa | ||
− | |||
− | |||
|journal=PLOS ONE | |journal=PLOS ONE | ||
|date=2018-08-01 | |date=2018-08-01 | ||
Line 413: | Line 833: | ||
|pubmedID=30067842 | |pubmedID=30067842 | ||
|pubmedCID=6070310 | |pubmedCID=6070310 | ||
− | |DOI= | + | |DOI=10.1371/journal.pone.0201445 |
|accessdate=2019-10-20 | |accessdate=2019-10-20 | ||
}}</ref> | }}</ref> | ||
− | + | ==== Swaziland ==== | |
DHS 2006-2007 - 22 vs 20 | DHS 2006-2007 - 22 vs 20 | ||
− | :"As Table 14.10 shows, the relationship between HIV prevalence and circumcision status is not in the expected direction. Circumcised men have a slightly higher HIV infection rate than men who are not circumcised (22 percent compared with 20 percent).<ref>http://www.measuredhs.com/pubs/pdf/FR202/FR202.pdf | + | :"As Table 14.10 shows, the relationship between [[HIV]] prevalence and circumcision status is not in the expected direction. [[Circumcised]] men have a slightly higher [[HIV]] infection rate than men who are [[Intact| not circumcised]] (22 percent compared with 20 percent).<ref>{{REFweb |
− | + | |url=http://www.measuredhs.com/pubs/pdf/FR202/FR202.pdf | |
+ | |title=Swaziland Demographic and Health Survey | ||
+ | |last= | ||
+ | |first= | ||
+ | |date=2006 | ||
+ | |accessdate=2022-06-15 | ||
+ | }}</ref> | ||
− | + | ==== Zambia ==== | |
− | The prevalence of HIV infection among men aged 15-29 has ''not'' decreased despite several campaigns to perform male circumcision. | + | The prevalence of [[HIV]] infection among men aged 15-29 has ''not'' decreased despite several campaigns to perform male circumcision. |
− | Garenne & Matthews (2019) report: | + | [[Michel Garenne|Garenne]] & Matthews (2019) report: |
<blockquote> | <blockquote> | ||
− | In a multivariate analysis, based on the 2013 DHS survey, circumcised men were found to have the same level of infection as uncircumcised men, after controlling for age, sexual behaviour and socioeconomic status. Lastly, circumcised men tended to have somewhat riskier sexual behaviour than uncircumcised men. This study, based on large representative samples of the Zambian population, questions the current strategy of mass circumcision campaigns in southern and eastern Africa.<ref name="garenne-matthews2019">{{REFjournal | + | In a multivariate analysis, based on the 2013 DHS survey, [[circumcised]] men were found to have the same level of infection as [[uncircumcised]] men, after controlling for age, sexual behaviour and socioeconomic status. Lastly, circumcised men tended to have somewhat riskier sexual behaviour than [[uncircumcised]] men. This study, based on large representative samples of the Zambian population, questions the current strategy of mass circumcision campaigns in southern and eastern Africa.<ref name="garenne-matthews2019">{{REFjournal |
|last=Garenne | |last=Garenne | ||
− | | | + | |init=M |
− | |author-link= | + | |author-link=Michel Garenne |
|last2=Matthews | |last2=Matthews | ||
− | | | + | |init2=A |
|author2-link= | |author2-link= | ||
|etal=no | |etal=no | ||
|title=Voluntary medical male circumcision and HIV in Zambia: expectations and observations | |title=Voluntary medical male circumcision and HIV in Zambia: expectations and observations | ||
− | |||
− | |||
|journal=J Biosoc Sci | |journal=J Biosoc Sci | ||
|date=2019-10-14 | |date=2019-10-14 | ||
|volume=Epub ahead of print | |volume=Epub ahead of print | ||
− | |||
|pages=1-13 | |pages=1-13 | ||
− | |||
− | |||
|pubmedID=31608845 | |pubmedID=31608845 | ||
− | |||
|DOI=10.1017/S0021932019000634 | |DOI=10.1017/S0021932019000634 | ||
|accessdate=2019-10-19 | |accessdate=2019-10-19 | ||
Line 452: | Line 872: | ||
</blockquote> | </blockquote> | ||
− | + | === Malaysia === | |
− | According to Malaysian AIDS Council vice-president Datuk Zaman Khan, more than 70% of the 87,710 HIV/AIDS sufferers in the country are Muslims. In Malaysia, most, if not all Muslim men are circumcised, whereas circumcision is uncommon in the non-Muslim community. 60% of the Malaysian population is Muslim, which means that HIV is spreading in the community where most men are circumcised at an even faster rate, than in the community where most men are intact.<ref | + | According to Malaysian [[AIDS]] Council vice-president Datuk Zaman Khan, more than 70% of the 87,710 [[HIV]]/[[AIDS]] sufferers in the country are Muslims. In Malaysia, most, if not all Muslim men are circumcised, whereas circumcision is uncommon in the non-Muslim community. 60% of the Malaysian population is Muslim, which means that [[HIV]] is spreading in the community where most men are circumcised at an even faster rate, than in the community where most men are intact.<ref{{REFweb |
+ | |url=http://www.mmail.com.my/content/39272-72-percent-aidshiv-sufferers-malaysia-are-muslims-says-council | ||
+ | |title= | ||
+ | |last= | ||
+ | |first= | ||
+ | |date= | ||
+ | |accessdate=2022-06-15 | ||
+ | }}></ref> | ||
+ | |||
+ | Interestingly enough, Malaysia is home to the [[TARA KLamp]], a controversial circumcision device being marketed in KwaZulu Natal, Africa in the name of [[HIV]] prevention. | ||
− | + | === Philippines === | |
+ | [[Tuli]] or male circumcision, a nearly compulsory cultural practice in the Philippine Islands, causes 93 percent of Filipino males to be [[circumcised]]. | ||
+ | In the 2010 Global [[AIDS]] report released by UNAIDS in late November, the Philippines was one of seven nations in the world which reported over 25 percent in new [[HIV]] infections between 2001 and 2009, whereas other countries have either stabilized or shown significant declines in the rate of new infections. Among all countries in Asia, only the Philippines and Bangladesh are reporting increases in [[HIV]] cases, with others either stable or decreasing. <ref>http://globalnation.inquirer.net/news/breakingnews/view/20110102-312124/Philippines-HIVAIDS-problem-worries-UN</ref> | ||
− | + | The statistics suggest that removal of the protective [[foreskin]] by [[circumcision]] increases the risk of contracting [[HIV]] infection. | |
− | |||
− | === | + | === [[Israel]] === |
− | Despite circumcision being near-universal, HIV is an increasing problem in Israel.<ref>{{REFweb | + | Despite circumcision being near-universal, [[HIV]] is an increasing problem in [[Israel]].<ref>{{REFweb |
|url=https://www.haaretz.com/1.4998790 | |url=https://www.haaretz.com/1.4998790 | ||
|title=Failing the AIDS Test | |title=Failing the AIDS Test | ||
Line 483: | Line 913: | ||
}}</ref> | }}</ref> | ||
− | + | === The United States === | |
− | In America, the majority of the male population is circumcised, approximately | + | In America, the majority of the male population is [[circumcised]], approximately 62%,<ref name="moore2015">{{REFweb |
+ | |url=https://today.yougov.com/topics/lifestyle/articles-reports/2015/02/03/younger-americans-circumcision | ||
+ | |title=Young Americans less supportive of circumcision at birth | ||
+ | |last=Moore | ||
+ | |first=Peter | ||
+ | |date=2015-02-03 | ||
+ | |accessdate=2022-06-15 | ||
+ | }}</ref> while in most countries in Europe, [[circumcision]] is uncommon. One would expect for there to be a lower transmission rates in the [[United States]], and for [[HIV]] to be rampant in Europe; [[HIV]] transmission rates are in fact higher in the [[United States]], where most men are [[circumcised]], than in various countries in Europe, where most men are [[intact]].<ref>http://data.unaids.org/pub/Report/1998/19981125_global_epidemic_report_en.pdf</ref> | ||
A common explanation given for this difference is the fact that sex education and instruction in the proper use of condoms is better executed in Europe than in the United States, where sex education is poor. | A common explanation given for this difference is the fact that sex education and instruction in the proper use of condoms is better executed in Europe than in the United States, where sex education is poor. | ||
− | However, it is precisely these reasons given, that sex education and condoms aren't catching on in Africa, why circumcision advocates say "mass circumcision campaigns" should be promoted in Africa. What failed in the United States is somehow supposed to work miracles in Africa. | + | However, it is precisely these reasons given, that sex education and condoms aren't catching on in Africa, why circumcision advocates say "mass circumcision campaigns" should be promoted in Africa. What failed in the [[United States]] is somehow supposed to work miracles in Africa. |
+ | == Studies with contrary conclusions == | ||
− | + | According to USAID, there appears no clear pattern of association between male circumcision and [[HIV]] prevalence—in 8 of 18 countries with data, [[HIV]] prevalence is lower among circumcised men, while in the remaining 10 countries it is higher.<ref>http://www.measuredhs.com/pubs/pdf/CR22/CR22.pdf</ref> | |
− | + | "Conclusions: We find a protective effect of circumcision in only one of the eight countries for which there are nationally-representative [[HIV]] seroprevalence data. The results are important in considering the development of circumcision-focused interventions within [[AIDS]] prevention programs."<ref>http://www.iasociety.org/Default.aspx?pageId=11&abstractId=2197431</ref> | |
− | + | Results: ...No consistent relationship between male circumcision and [[HIV]] risk was observed in most countries."<ref>"http://apha.confex.com/apha/134am/techprogram/paper_136814.htm</ref> | |
− | |||
− | Results: ...No consistent relationship between male circumcision and HIV risk was observed in most countries."<ref>"http://apha.confex.com/apha/134am/techprogram/paper_136814.htm</ref> | ||
== Findings == | == Findings == | ||
− | Male circumcision has been found not to decrease the risk of HIV and may in fact increase the risk of male to female transmission<ref>{{REFconference | + | Male circumcision has been found not to decrease the risk of [[HIV]] and may in fact increase the risk of male to female transmission<ref>{{REFconference |
|last=Castilho | |last=Castilho | ||
|first=E.A. | |first=E.A. | ||
Line 516: | Line 952: | ||
}}</ref><ref>{{REFjournal | }}</ref><ref>{{REFjournal | ||
|last=Guimaraes | |last=Guimaraes | ||
− | | | + | |init=MD |
|author-link= | |author-link= | ||
|last2=Vlahov | |last2=Vlahov | ||
− | | | + | |init2=D |
|last3=Castilho | |last3=Castilho | ||
− | | | + | |init3=EA |
|title=Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil (Rio de Janeiro Heterosexual Study Group) | |title=Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil (Rio de Janeiro Heterosexual Study Group) | ||
|journal=Arch Intern Med. | |journal=Arch Intern Med. | ||
Line 528: | Line 964: | ||
|issue=12 | |issue=12 | ||
|pages=1362-1368 | |pages=1362-1368 | ||
− | |||
|accessdate= | |accessdate= | ||
}}</ref><ref>{{REFconference | }}</ref><ref>{{REFconference | ||
Line 556: | Line 991: | ||
|publisher=International Herald Tribune | |publisher=International Herald Tribune | ||
|date=2007-03-06 | |date=2007-03-06 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
}}</ref> | }}</ref> | ||
== Follow-up studies == | == Follow-up studies == | ||
− | Using a population-based survey, Westercamp | + | Using a population-based survey, Westercamp et al. (2010) examined the behaviors, beliefs, and [[HIV]]/HSV-2 serostatus of men and women in the traditionally non-circumcising community of Kisumu, Kenya prior to establishment of voluntary medical male circumcision services. A total of 749 men and 906 women participated. Circumcision status was not associated with [[HIV]]/HSV-2 infection nor increased high risk sexual behaviors. In males, preference for being or becoming circumcised was associated with inconsistent condom use and increased lifetime number of sexual partners. Preference for circumcision was increased with the belief that circumcised men are less likely to become infected with [[HIV]].<ref>{{REFjournal |
|last=Westercamp | |last=Westercamp | ||
− | | | + | |init=M |
|last2=Bailey | |last2=Bailey | ||
− | | | + | |init2=RC |
|last3=Bukusi | |last3=Bukusi | ||
− | | | + | |init3=EA |
|last4=Montandon | |last4=Montandon | ||
− | | | + | |init4=M |
|last5=Kwena | |last5=Kwena | ||
− | | | + | |init5=Z |
|etal=yes | |etal=yes | ||
|title=Male Circumcision in the General Population of Kisumu, Kenya: Beliefs about Protection, Risk Behaviors, HIV, and STIs | |title=Male Circumcision in the General Population of Kisumu, Kenya: Beliefs about Protection, Risk Behaviors, HIV, and STIs | ||
Line 763: | Line 1,011: | ||
|volume=5 | |volume=5 | ||
|issue=12 | |issue=12 | ||
− | |||
|url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015552 | |url=http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0015552 | ||
− | |||
− | |||
− | |||
|DOI=10.1371/journal.pone.0015552 | |DOI=10.1371/journal.pone.0015552 | ||
|date=2010 | |date=2010 | ||
− | |||
}}</ref> | }}</ref> | ||
== Real-world == | == Real-world == | ||
− | An analysis of HIV prevalence compared to circumcision status in sub-Saharan Africa concluded that male circumcision is not associated with reduced HIV prevalence.<ref>{{REFjournal | + | An analysis of [[HIV]] prevalence compared to circumcision status in sub-Saharan Africa concluded that male circumcision is not associated with reduced [[HIV]] prevalence.<ref>{{REFjournal |
|last=Garenne | |last=Garenne | ||
− | | | + | |init=M |
+ | |author-link=Michel Garenne | ||
|title=Long-term population effects of male circumcision in generalized HIV epidemics in sub-Saharan Africa | |title=Long-term population effects of male circumcision in generalized HIV epidemics in sub-Saharan Africa | ||
+ | |url=http://www.circumstitions.com/Docs/garenne-2.pdf | ||
+ | |format=PDF | ||
|journal=Afr J AIDS Res | |journal=Afr J AIDS Res | ||
|date=2008 | |date=2008 | ||
Line 784: | Line 1,030: | ||
|issue=1 | |issue=1 | ||
|pages=1-8 | |pages=1-8 | ||
− | }}</ref> Another study on circumcision prevalence compared to HIV in the general South African population concluded: “Circumcision had no protective effect on HIV transmission.”<ref>{{REFjournal | + | }}</ref> Another study on circumcision prevalence compared to [[HIV]] in the general South African population concluded: “Circumcision had no protective effect on [[HIV]] transmission.”<ref>{{REFjournal |
|last=Connolly | |last=Connolly | ||
− | | | + | |init=C |
|last2=Simbayi | |last2=Simbayi | ||
− | | | + | |init2=LC |
|last3=Shanmugam | |last3=Shanmugam | ||
− | | | + | |init3=R |
|last4=Nqeketo | |last4=Nqeketo | ||
− | | | + | |init4=A |
|title=Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002 | |title=Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002 | ||
+ | |url=http://artemide.bioeng.washington.edu/connolly_nqeketo_male_samj_2008_98_10.pdf | ||
+ | |format=PDF | ||
|journal=S Afr Med J | |journal=S Afr Med J | ||
|date=2008 | |date=2008 | ||
|volume=98 | |volume=98 | ||
|pages=789-794 | |pages=789-794 | ||
− | }}</ref> When commercial sex worker patterns are controlled, male circumcision is not signifıcantly associated with lower HIV prevalence.<ref>{{REFjournal | + | }}</ref> When commercial sex worker patterns are controlled, male circumcision is not signifıcantly associated with lower [[HIV]] prevalence.<ref>{{REFjournal |
|last=Talbott | |last=Talbott | ||
− | | | + | |init=JR |
|title=Size matters: the number of prostitutes and the global HIV/AIDS pandemic | |title=Size matters: the number of prostitutes and the global HIV/AIDS pandemic | ||
+ | |url=http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000543 | ||
|journal=PloS One | |journal=PloS One | ||
|date=2007 | |date=2007 | ||
Line 807: | Line 1,056: | ||
|issue=6 | |issue=6 | ||
|page=e543 | |page=e543 | ||
− | + | }}</ref> Mathematical impact modeling of circumcision, antiretroviral therapy (ART), and condom use for South Africa concluded: “Male circumcision was found to have considerably lower impact than condom use or anti-retroviral therapy on [[HIV]] infection rates and death rates.”<ref>{{REFconference | |
− | }}</ref> Mathematical impact modeling of circumcision, antiretroviral therapy (ART), and condom use for South Africa concluded: “Male circumcision was found to have considerably lower impact than condom use or anti-retroviral therapy on HIV infection rates and death rates.”<ref>{{REFconference | ||
|last=Lima | |last=Lima | ||
|first=V. | |first=V. | ||
|author-link= | |author-link= | ||
− | |coauthors=Anema A., Wood R., | + | |coauthors=Anema A., Wood R., et al. |
|coauthors-link= | |coauthors-link= | ||
|title=The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model | |title=The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model | ||
Line 822: | Line 1,070: | ||
|dateto= | |dateto= | ||
|accessdate= | |accessdate= | ||
− | }}</ref> Both the U.S. and sub-Saharan Africa have relatively high incidence rates of HIV infection, considering that about 75% of U.S. men and about 70% of sub-Saharan African men are circumcised—higher percentages than in most other regions or countries with lower prevalence of HIV.<ref>{{REFjournal | + | }}</ref> Both the U.S. and sub-Saharan Africa have relatively high incidence rates of [[HIV]] infection, considering that about 75% of U.S. men and about 70% of sub-Saharan African men are circumcised—higher percentages than in most other regions or countries with lower prevalence of [[HIV]].<ref name="Green etal 2010">{{REFjournal |
|last=Green | |last=Green | ||
− | | | + | |init=LW |
|last2=Travis | |last2=Travis | ||
− | | | + | |init2=JW |
|last3=McAllister | |last3=McAllister | ||
− | | | + | |init3=RG |
|author3-link=Ryan McAllister | |author3-link=Ryan McAllister | ||
|last4=Peterson | |last4=Peterson | ||
− | | | + | |init4=KW |
|last5=Vardanyan | |last5=Vardanyan | ||
− | | | + | |init5=AN |
|last6=Craig | |last6=Craig | ||
− | | | + | |init6=A |
|title=Male circumcision and HIV prevention insufficient evidence and neglected external validity | |title=Male circumcision and HIV prevention insufficient evidence and neglected external validity | ||
+ | |url=https://www.arclaw.org/wp-content/uploads/Green-Circ-HIV-Prev-Insufficient-AmJPrevMed-2010.pdf | ||
+ | |format=PDF | ||
|journal=Am J Prev Med | |journal=Am J Prev Med | ||
+ | |publisher=Department of Epidemiology and Biostatistics, {{UNI|University of California|UCSF}} at San Francisco, USA | ||
|date=2010-11 | |date=2010-11 | ||
|volume=39 | |volume=39 | ||
|issue=5 | |issue=5 | ||
|pages=479-482 | |pages=479-482 | ||
− | |||
|pubmedID=20965388 | |pubmedID=20965388 | ||
}}</ref> | }}</ref> | ||
− | There is no clear pattern of association between male circumcision and HIV prevalence. In 10 out of 18 countries, HIV prevalence is higher amongst circumcised men.<ref>{{REFdocument | + | There is no clear pattern of association between male circumcision and [[HIV]] prevalence. In 10 out of 18 countries, [[HIV]] prevalence is higher amongst circumcised men.<ref>{{REFdocument |
|contribution=Levels and spread of HIV seroprevalence and associated factors: Evidence from national household surveys | |contribution=Levels and spread of HIV seroprevalence and associated factors: Evidence from national household surveys | ||
|title=DHS Comparative Reports 22 | |title=DHS Comparative Reports 22 | ||
Line 855: | Line 1,105: | ||
|date= | |date= | ||
|accessdate=2019-09-29 | |accessdate=2019-09-29 | ||
− | }}</ref> Furthermore, HIV prevalence was found to be higher amongst circumcised males and females for virgins and adolescents in Kenya, Lesotho, and Tanzania.<ref>{{REFjournal | + | }}</ref> Furthermore, [[HIV]] prevalence was found to be higher amongst circumcised males and females for virgins and adolescents in Kenya, Lesotho, and Tanzania.<ref>{{REFjournal |
|last=Brewer | |last=Brewer | ||
|first=Devon D. | |first=Devon D. | ||
+ | |init=DD | ||
+ | |last2=Potterat | ||
|first2=John J. | |first2=John J. | ||
− | | | + | |init2=JJ |
+ | |last3=Roberts Jr | ||
|first3=John M. | |first3=John M. | ||
− | | | + | |init3=JM |
+ | |last4=Brody | ||
|first4=Stuart | |first4=Stuart | ||
− | | | + | |init4=S |
|title=Male and Female Circumcision Associated With Prevalent HIV Infection in Virgins and Adolescents in Kenya, Lesotho, and Tanzania | |title=Male and Female Circumcision Associated With Prevalent HIV Infection in Virgins and Adolescents in Kenya, Lesotho, and Tanzania | ||
+ | |url=https://www.orchidproject.org/wp-content/uploads/2019/03/Male_Female_Circumcision_Prevalent_HIV_Infection_Virgins_Adolescents_Kenya_Lesotho_Tanzania.pdf | ||
+ | |format=PDF | ||
|journal=Annals of Epidemiology | |journal=Annals of Epidemiology | ||
|volume=17 | |volume=17 | ||
|issue=3 | |issue=3 | ||
|pages=217.e1-217.e12 | |pages=217.e1-217.e12 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|note=Annals of Epidemiology | |note=Annals of Epidemiology | ||
|accessdate=2011-06-02 | |accessdate=2011-06-02 | ||
}}</ref> | }}</ref> | ||
− | + | [[David Gisselquist]], {{PhD}}, who has studied health care practices in sub-Saharan Africa, finds that much of health care, especially injection practices, in Africa is non-sterile, and is likely the cause of the high incidence of [[HIV]] infection. He notes that the consensus to make sex the primary cause of infection was determined in the 1980s and is likely to be inaccurate, because it does not give sufficient weight to medical transmission of [[HIV]] infection.<ref name=”gisselquist2002”>{{REFjournal | |
− | |last= | + | |last=Gisselquist |
− | | | + | |init=D |
− | |last2= | + | |last2=Rothenberg |
− | | | + | |init2=R |
− | |last3 | + | |last3=Potterat |
− | + | |init3=J | |
− | + | |last4=Drucker | |
− | + | |init4=E | |
− | + | |title=Non-sexual transmission of HIV has been overlooked in developing countries | |
− | + | |url=https://europepmc.org/article/med/11809652#free-full-text | |
− | + | |journal=Br Med J | |
− | | | + | |date=2002 |
− | | | + | |volume=324 |
− | | | + | |issue=7331 |
− | | | + | |page=235 |
− | | | + | }}</ref> Gisselquist et al. argue strongly that statistical evidence indicates that 5/6s of the [[HIV]] infection in Africa is non-sexual.<ref name=”gisselquist2003”>{{REFjournal |
− | |||
− | |journal= | ||
− | |date= | ||
− | |volume= | ||
− | |issue= | ||
− | | | ||
− | }}</ref><ref>{{REFjournal | ||
|last=Gisselquist | |last=Gisselquist | ||
− | | | + | |init=D |
|last2=Potterat | |last2=Potterat | ||
− | | | + | |init2=JJ |
− | | | + | |title=Heterosexual transmission of HIV in Africa: an empiric estimate |
− | | | + | |url=http://www.cirp.org/library/disease/HIV/gisselquist2/gisselquist2.pdf |
− | + | |format=PDF | |
− | |||
− | | | ||
|journal=Int J STD AIDS | |journal=Int J STD AIDS | ||
|date=2003 | |date=2003 | ||
|volume=14 | |volume=14 | ||
− | |pages= | + | |pages=162-73 |
}}</ref><ref>{{REFjournal | }}</ref><ref>{{REFjournal | ||
|last=Gisselquist | |last=Gisselquist | ||
− | | | + | |init=D |
|last2=Potterat | |last2=Potterat | ||
− | | | + | |init2=JJ |
|last3=Brody | |last3=Brody | ||
− | | | + | |init3=S |
|title=Running on empty: sexual co-factors are insufficient to fuel Africa's turbocharged HIV epidemic | |title=Running on empty: sexual co-factors are insufficient to fuel Africa's turbocharged HIV epidemic | ||
+ | |url=https://www.researchgate.net/profile/John-Potterat/publication/8479267_Running_on_empty_Sexual_co-factors_are_insufficient_to_fuel_Africa%27s_turbocharged_HIV_epidemic/links/00b7d529d10fbac5c9000000/Running-on-empty-Sexual-co-factors-are-insufficient-to-fuel-Africas-turbocharged-HIV-epidemic.pdf | ||
+ | |format=PDF | ||
|journal=Int J STD AIDS | |journal=Int J STD AIDS | ||
|date=2004 | |date=2004 | ||
|volume=15 | |volume=15 | ||
|issue=7 | |issue=7 | ||
− | |pages=442- | + | |pages=442-52 |
− | }}</ref> | + | }}</ref> Male circumcision has been proposed to reduce the incidence of sexual transmission of [[HIV]]. In reality, it actually increases the sexual transmission of [[HIV]]. Even if it did work, it would be ineffective against non-sexual transmission by unsafe health care. Furthermore, non-sterile health care could mean that the circumcision operation could transmit the [[HIV]] infection to the patient.<ref>{{REFjournal |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|last=Nyindo | |last=Nyindo | ||
− | | | + | |init=M |
|title=Complementary factors contributing to the rapid spread of HIV-I in sub-Saharan Africa: a review | |title=Complementary factors contributing to the rapid spread of HIV-I in sub-Saharan Africa: a review | ||
− | |journal=East | + | |url=https://www.ajol.info//index.php/eamj/article/view/9293 |
+ | |journal=East African Medical Journal | ||
|date=2005 | |date=2005 | ||
|volume=82 | |volume=82 | ||
Line 966: | Line 1,186: | ||
== Problems with promoting circumcision as HIV prevention policy == | == Problems with promoting circumcision as HIV prevention policy == | ||
− | The fact that the World Health Organization is corrupt is now well-established. | + | The fact that the [[World Health Organization]] is corrupt is now well-established: |
+ | |||
+ | Circumcision advocates use the discredited RCT African studies and WHO's endorsement based on them as proof "beyond reasonable doubt" that circumcision "reduces the risk of [[HIV]]." However, there are problems with the WHO's endorsement, as the studies on which it is based on suffer various flaws and confounding factors that bring their credibility in to question, many of which will be discussed in this article. | ||
+ | |||
+ | On their [http://www.who.int/hiv/topics/malecircumcision/en/ website], the WHO acknowledges that, ''"[m]ale circumcision provides only partial protection,"'' and that it should be part of a ''"comprehensive [[HIV]] prevention package"'' that includes [[HIV]] testing and counseling services, treatment for STD infections, the promotion of safer sex practices and the provision of condoms and the promotion of their correct and consistent use. | ||
− | + | [[Robert S. Van Howe|Van Howe]] & Boyle (2018) pointed out numerous reasons that one should doubt the published results of the randomised clinical trials (RCTs)<ref name= "vanhowe2018">{{REFjournal | |
+ | |last=Van Howe | ||
+ | |first=Robert S. | ||
+ | |init=RS | ||
+ | |author-link=Robert S. Van Howe | ||
+ | |last2=Boyle | ||
+ | |first2=Gregory J. | ||
+ | |init2=GJ | ||
+ | |author2-link=Gregory J. Boyle | ||
+ | |etal=no | ||
+ | |title=Meta-analysis of HIV-acquisition studies incomplete and unstable | ||
+ | |journal=BJU Int | ||
+ | |location= | ||
+ | |date=2018-10-31 | ||
+ | |volume= | ||
+ | |issue= | ||
+ | |pages= | ||
+ | |url=https://www.bjuinternational.com/letters/meta-analysis-circumcision-incomplete-unstable/ | ||
+ | |archived= | ||
+ | |quote=Given the effectiveness of condoms, the lack of consistent findings on national levels, the methodologically flawed RCTs, the lack of translational research, and the impressive potential uptake and effectiveness of pre-exposure prophylaxis, circumcision as an intervention to prevent HIV infection should be treated with greater scepticism. | ||
+ | |pubmedID= | ||
+ | |pubmedCID= | ||
+ | |DOI= | ||
+ | |accessdate=2020-09-05 | ||
+ | }}</ref> | ||
− | + | [[George C. Denniston]], {{MD}}, {{MPH}}, the president of [[Doctors Opposing Circumcision (D.O.C.)]], in a letter to Ambassador Deborah L. Birx, {{MD}}, {{MPH}}, (2020), the head of the President’s Emergency Plan for AIDS Relief (PEPFAR) has called on [[PEPFAR]] to suspend the provision of male [[circumcision]] because it is ineffective and may increase the reception of [[HIV]] infection due to the loss of [[Immunological and protective function of the foreskin| immunological protections]] of the [[foreskin]], and to focus on the provision of anti-retroviral therapy and condoms.<ref name="denniston2020">{{REFdocument | |
+ | |title=World Health Organization, HIV, and male circumcision | ||
+ | |url=https://pool.intactiwiki.org/images/2020-06-15b_LettertoPEPFAR.pdf | ||
+ | |contribution= | ||
+ | |last=Denniston | ||
+ | |first=George C. | ||
+ | |publisher=[[Doctors Opposing Circumcision (D.O.C.)]] | ||
+ | |format= | ||
+ | |date=2020-06-29 | ||
+ | |accessdate=2020-09-02 | ||
+ | }}</ref> | ||
+ | |||
+ | Fish et al. (2020), speaking for the [[VMMC Experience Project]], published an article that described the PEPFAR program to circumcise African men, as racist and neo-colonialist.<ref name="fish2020">{{REFjournal | ||
+ | |last=Fish | ||
+ | |first=Max | ||
+ | |init= | ||
+ | |author-link= | ||
+ | |last2=Shavisi | ||
+ | |first2=Arianne | ||
+ | |init2= | ||
+ | |author2-link= | ||
+ | |last3=Gwaambuka | ||
+ | |first3=Tatenda | ||
+ | |init3= | ||
+ | |author3-link= | ||
+ | |last4=Tangwa | ||
+ | |first4=Godfrey B. | ||
+ | |init4= | ||
+ | |author4-link= | ||
+ | |last5=Ncayiyana | ||
+ | |first5=Daniel | ||
+ | |init5= | ||
+ | |author5-link= | ||
+ | |last6=Earp | ||
+ | |first6=Brian D | ||
+ | |init6= | ||
+ | |author6-link=Brian D. Earp | ||
+ | |etal=no | ||
+ | |title=A new Tuskegee? Unethical human experimentation and Western neocolonialism in the mass circumcision of African men | ||
+ | |trans-title= | ||
+ | |language=English | ||
+ | |journal=Developing World Bioeth | ||
+ | |location= | ||
+ | |date=2020-09-09 | ||
+ | |volume=00 | ||
+ | |issue= | ||
+ | |article= | ||
+ | |page= | ||
+ | |pages=1-16 | ||
+ | |url=http://www.circumcisionharm.org/images-circharm.org/Fish%20Earp%20New%20Tuskegee%20Dev%20World%20Bioeth%202020.pdf | ||
+ | |archived= | ||
+ | |quote= | ||
+ | |pubmedID=32909369 | ||
+ | |pubmedCID= | ||
+ | |DOI= | ||
+ | |accessdate=2021-04-07 | ||
+ | }}</ref> | ||
− | + | Threre now is credible evidence that the massive, expensive African circumcision programs have ''not'' been effective in preventing [[HIV]] infection. | |
== Increased risk to women == | == Increased risk to women == | ||
A recent prospective study<ref>{{REFjournal | A recent prospective study<ref>{{REFjournal | ||
|last=Turner | |last=Turner | ||
− | | | + | |init=AN |
|last2=Morrison | |last2=Morrison | ||
− | | | + | |init2=CS |
|last3=Padian | |last3=Padian | ||
− | | | + | |init3=NS |
|etal=yes | |etal=yes | ||
|title=Men’s circumcision status and women’s risk of HIV acquisition in Zimbabwe and Uganda | |title=Men’s circumcision status and women’s risk of HIV acquisition in Zimbabwe and Uganda | ||
Line 990: | Line 1,294: | ||
}}</ref> showed that male circumcision offered no protection to women, and an RCCT<ref>{{REFjournal | }}</ref> showed that male circumcision offered no protection to women, and an RCCT<ref>{{REFjournal | ||
|last=Wawer | |last=Wawer | ||
− | | | + | |init=MJ |
|last2=Makumbi | |last2=Makumbi | ||
− | | | + | |init2=F |
|last3=Kigozi | |last3=Kigozi | ||
− | | | + | |init3=G |
|etal=yes | |etal=yes | ||
|title=Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial | |title=Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial | ||
Line 1,001: | Line 1,305: | ||
|volume374 | |volume374 | ||
|pages=229-237 | |pages=229-237 | ||
− | }}</ref> found that male circumcision actually increased the risk to women. Women also are placed at greater risk from unsafe sex practices when they, or their circumcised male partners, wrongly believe that with circumcision they are immune to HIV and therefore they choose not to use condoms.<ref>{{REFweb | + | }}</ref> found that male circumcision actually increased the risk to women. Women also are placed at greater risk from unsafe sex practices when they, or their circumcised male partners, wrongly believe that with circumcision they are immune to [[HIV]] and therefore they choose not to use condoms.<ref>{{REFweb |
|last=Nyakairu | |last=Nyakairu | ||
|first=F. | |first=F. | ||
Line 1,007: | Line 1,311: | ||
|publisher=Reuters Africa | |publisher=Reuters Africa | ||
|date=2008-08-13 | |date=2008-08-13 | ||
− | |url= | + | |url=https://www.reuters.com/article/idUSLD23235720080813 |
}}</ref><ref>{{REFweb | }}</ref><ref>{{REFweb | ||
|title=Circumcision gives men an excuse not to use condoms | |title=Circumcision gives men an excuse not to use condoms | ||
Line 1,020: | Line 1,324: | ||
* How male circumcision programs, or being circumcised, will influence human behavior. | * How male circumcision programs, or being circumcised, will influence human behavior. | ||
* The sidelining of women when considering male circumcision as a prevention method. | * The sidelining of women when considering male circumcision as a prevention method. | ||
− | * The tendency of both men and women to ascribe undue power to a technical fıx for what must remain a matter of human control, as in the use of condoms and other safe sex practices.<ref | + | * The tendency of both men and women to ascribe undue power to a technical fıx for what must remain a matter of human control, as in the use of condoms and other safe sex practices.<ref name="Green etal 2010"/> |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
== Effective prevention == | == Effective prevention == | ||
Line 1,046: | Line 1,330: | ||
{| class="wikitable" border="1" style="float:right; font-size:85%; margin-left:15px;" | {| class="wikitable" border="1" style="float:right; font-size:85%; margin-left:15px;" | ||
|- style="background:#efefef;" | |- style="background:#efefef;" | ||
− | |+ Estimated per act risk for acquisition<br/>of HIV by exposure route (US only) <ref name=MMWR3>{{REFjournal | + | |+ Estimated per act risk for acquisition<br/>of [[HIV]] by exposure route (US only) <ref name=MMWR3>{{REFjournal |
|last=Smith | |last=Smith | ||
− | | | + | |init=DK |
|last2=Grohskopf | |last2=Grohskopf | ||
− | | | + | |init2=LA |
|last3=Black | |last3=Black | ||
− | | | + | |init3=RJ |
|etal=yes | |etal=yes | ||
|title=Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States | |title=Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States | ||
Line 1,074: | Line 1,358: | ||
| 9,000<ref name=Donegan>{{REFjournal | | 9,000<ref name=Donegan>{{REFjournal | ||
|last=Donegan | |last=Donegan | ||
− | | | + | |init=E |
|last2=Stuart | |last2=Stuart | ||
− | | | + | |init2=M |
|last3=Niland | |last3=Niland | ||
− | | | + | |init3=JC |
|etal=yes | |etal=yes | ||
|title=Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations | |title=Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations | ||
Line 1,097: | Line 1,381: | ||
| 2,500<ref name=Coovadia>{{REFjournal | | 2,500<ref name=Coovadia>{{REFjournal | ||
|last=Coovadia | |last=Coovadia | ||
− | | | + | |init=H |
|title=Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS | |title=Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS | ||
|journal=N. Engl. J. Med. | |journal=N. Engl. J. Med. | ||
Line 1,115: | Line 1,399: | ||
| 67<ref name=Kaplan>{{REFjournal | | 67<ref name=Kaplan>{{REFjournal | ||
|last=Kaplan | |last=Kaplan | ||
− | | | + | |init=EH |
|last2=Heimer | |last2=Heimer | ||
− | | | + | |init2=R |
|title=HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data | |title=HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data | ||
|journal=J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. | |journal=J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. | ||
Line 1,135: | Line 1,419: | ||
| 30<ref name=Bell>{{REFjournal | | 30<ref name=Bell>{{REFjournal | ||
|last=Bell | |last=Bell | ||
− | | | + | |init=DM |
|title=Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview | |title=Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview | ||
− | |journal=Am | + | |journal=Am J Med |
|volume=102 | |volume=102 | ||
|issue=5B | |issue=5B | ||
Line 1,168: | Line 1,452: | ||
}}</ref><ref name=Varghese>{{REFjournal | }}</ref><ref name=Varghese>{{REFjournal | ||
|last=Varghese | |last=Varghese | ||
− | | | + | |init=B |
|last2=Maher | |last2=Maher | ||
− | | | + | |init2=JE |
|last3=Peterman | |last3=Peterman | ||
− | | | + | |init3=TA |
|last4=Branson | |last4=Branson | ||
− | | | + | |init4=BM |
|last5=Steketee | |last5=Steketee | ||
− | | | + | |init5=RW |
|title=Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use | |title=Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use | ||
− | |journal=Sex | + | |journal=Sex Transm Dis |
|volume=29 | |volume=29 | ||
|issue=1 | |issue=1 | ||
Line 1,197: | Line 1,481: | ||
| 10<ref name=ESG /><ref name=Varghese /><ref name=Leynaert>{{REFjournal | | 10<ref name=ESG /><ref name=Varghese /><ref name=Leynaert>{{REFjournal | ||
|last=Leynaert | |last=Leynaert | ||
− | | | + | |init=B |
|last2=Downs | |last2=Downs | ||
− | | | + | |init2=AM |
|last3=de Vincenzi | |last3=de Vincenzi | ||
− | | | + | |init3=I |
|title=Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV | |title=Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV | ||
− | |journal=Am | + | |journal=Am J Epidemiol |
|volume=148 | |volume=148 | ||
|issue=1 | |issue=1 | ||
Line 1,227: | Line 1,511: | ||
! colspan=5 style="border-right:0;"| <sup>*</sup> assuming no condom use <br /> <sup>§</sup> source refers to oral intercourse<br/>performed on a man | ! colspan=5 style="border-right:0;"| <sup>*</sup> assuming no condom use <br /> <sup>§</sup> source refers to oral intercourse<br/>performed on a man | ||
|} | |} | ||
− | The three main transmission routes of HIV are [[sexual contact]], exposure to infected body fluids or tissues, and from mother to [[fetus]] or child during [[perinatal]] period. It is possible to find HIV in the [[saliva]], [[tears]], and [[urine]] of infected individuals, but there are no recorded cases of infection by these secretions, and the risk of infection is negligible.<ref>{{REFweb | + | The three main transmission routes of [[HIV]] are [[sexual contact]], exposure to infected body fluids or tissues, and from mother to [[fetus]] or child during [[perinatal]] period. It is possible to find [[HIV]] in the [[saliva]], [[tears]], and [[urine]] of infected individuals, but there are no recorded cases of infection by these secretions, and the risk of infection is negligible.<ref>{{REFweb |
|url=http://www.avert.org/aids.htm | |url=http://www.avert.org/aids.htm | ||
|title=Facts about AIDS & HIV | |title=Facts about AIDS & HIV | ||
Line 1,235: | Line 1,519: | ||
|date= | |date= | ||
|accessdate=2007-11-30 | |accessdate=2007-11-30 | ||
− | }}</ref> Anti-retroviral treatment of infected patients also significantly reduces their ability to transmit HIV to others, by reducing the amount of virus in their bodily fluids to undetectable levels.<ref>[http://www.npr.org/templates/story/story.php?storyId=128495103 NPR.org]</ref> | + | }}</ref> Anti-retroviral treatment (ART) of infected patients also significantly reduces their ability to transmit [[HIV]] to others, by reducing the amount of virus in their bodily fluids to undetectable levels.<ref>[http://www.npr.org/templates/story/story.php?storyId=128495103 NPR.org]</ref> <ref name="denniston2020" /> |
+ | |||
+ | == Population-based studies == | ||
+ | {{Population-based studies}} | ||
+ | |||
+ | ==Two African surveys== | ||
+ | The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa. | ||
+ | |||
+ | French scientist [[Michel Garenne]], Ph.D. has published two reports in 2022 comparing the incidence of HIV infection in [[circumcised]] and [[intact]] men. | ||
+ | |||
+ | In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported: | ||
+ | <blockquote> | ||
+ | In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.<ref name="garenne2022A">{{REFjournal | ||
+ | |last=Garenne | ||
+ | |first=Michel | ||
+ | |init=M | ||
+ | |author-link=Michel Garenne | ||
+ | |title=Changing relationships between HIV prevalence and circumcision in Lesotho | ||
+ | |url=https://pubmed.ncbi.nlm.nih.gov/35373731/ | ||
+ | |date=2022-04-04 | ||
+ | |journal=J Biosoc Sci | ||
+ | |volume=online ahead of print | ||
+ | |pages=1-16 | ||
+ | |DOI=10.1017/S0021932022000153 | ||
+ | |pubmedID=35373731 | ||
+ | |accessdate=2022-10-28 | ||
+ | }}</ref> | ||
+ | </blockquote> | ||
+ | |||
+ | In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported: | ||
+ | <blockquote> | ||
+ | "Results matched earlier observations made in South Africa that [[circumcised]] and [[intact]] men had similar levels of HIV infection."<ref name="garenne2022B">{{REFjournal | ||
+ | |last=Garenne | ||
+ | |first=Michael | ||
+ | |init=M | ||
+ | |author-link= | ||
+ | |etal=no | ||
+ | |title=Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa | ||
+ | |trans-title= | ||
+ | |language= | ||
+ | |journal=J Biosoc Sci | ||
+ | |location= | ||
+ | |date=2022-10-26 | ||
+ | |season= | ||
+ | |volume= | ||
+ | |issue= | ||
+ | |article= | ||
+ | |page= | ||
+ | |pages=1-13 | ||
+ | |url=https://www.cambridge.org/core/journals/journal-of-biosocial-science/article/abs/ageincidence-and-prevalence-of-hiv-among-intact-and-circumcised-men-an-analysis-of-phia-surveys-in-southern-africa/CAA7E7BD5A9844F41C6B7CC3573B9E50 | ||
+ | |archived= | ||
+ | |quote= | ||
+ | |pubmedID=36286328 | ||
+ | |pubmedCID= | ||
+ | |DOI=10.1017/S0021932022000414 | ||
+ | |accessdate=2022-10-27 | ||
+ | }}</ref></blockquote> | ||
+ | |||
+ | {{SEEALSO}} | ||
+ | * [[Foreskin]] | ||
+ | * [[Immunological and protective function of the foreskin]] | ||
+ | * [[PEPFAR]] | ||
+ | * [[Preputial sac]] | ||
+ | * [[World Health Organization]] | ||
+ | * [[Bill & Melinda Gates Foundation]] | ||
{{LINKS}} | {{LINKS}} | ||
Line 1,251: | Line 1,599: | ||
|accessdate=2019-12-07 | |accessdate=2019-12-07 | ||
|format=PDF | |format=PDF | ||
+ | |quote= | ||
+ | }} | ||
+ | * {{REFweb | ||
+ | |url=https://www.doctorsopposingcircumcision.org/for-professionals/alleged-medical-benefits/hivaids/ | ||
+ | |archived= | ||
+ | |title=HIV/AIDS | ||
+ | |trans-title= | ||
+ | |language=English | ||
+ | |last= | ||
+ | |first= | ||
+ | |author-link= | ||
+ | |publisher=[[Doctors Opposing Circumcision (D.O.C.)]] | ||
+ | |website= | ||
+ | |date=2016 | ||
+ | |accessdate=2020-06-11 | ||
+ | |format= | ||
+ | |quote= | ||
+ | }} | ||
+ | * {{REFweb | ||
+ | |url=https://www.vmmcproject.org/ | ||
+ | |title=The VMMC Experience Project | ||
+ | |last= | ||
+ | |first= | ||
+ | |accessdate=2021-03-07 | ||
+ | }} | ||
+ | * {{REFweb | ||
+ | |url=https://foregen.webflow.io/commentarium-articles/international-contractors-are-profiteering-from-new-circumcision-devices | ||
+ | |archived= | ||
+ | |title=International Contractors are Profiteering from New Circumcision Devices | ||
+ | |trans-title= | ||
+ | |language=English | ||
+ | |last=[[Foregen]] Staff | ||
+ | |first= | ||
+ | |author-link= | ||
+ | |publisher=[[Foregen]] | ||
+ | |website= | ||
+ | |date=2021-03-08 | ||
+ | |accessdate=2021-03-08 | ||
+ | |format= | ||
|quote= | |quote= | ||
}} | }} | ||
− | {{ | + | {{ABBR}} |
− | |||
− | |||
− | |||
{{REF}} | {{REF}} | ||
Line 1,263: | Line 1,647: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Sexually transmitted disease]] | [[Category:Sexually transmitted disease]] | ||
+ | [[Category:Circumcision in Africa]] | ||
[[Category:From Intactipedia]] | [[Category:From Intactipedia]] |
Latest revision as of 14:34, 31 May 2024
Circumcision and HIV discusses the relationship of male circumcision and HIV infection. For a discussion of circumcision and other sexually transmitted infections, see Circumcision and STDs.
Recently, circumcision has been heavily promoted as a method of preventing HIV. The World Health Organization (WHO), now known to be corrupted, hasitly endorsed male circumcision as a form of HIV prevention in 2007, based on three studies (2005) & (2007) conducted in Africa (Kenya, South Africa, and Uganda) which claim that male circumcision is supposed to "reduce the risk of HIV transmission by 60%."[1] This endorsement has lead to the institution of "mass circumcision campaigns" aimed at circumcising the majority of African men in a few countries,[2] and the promotion of male circumcision as a HIV-prevention method by the Centers for Disease Control[3][4][5]
Contents
- 1 Origin of the circumcision/HIV hypothesis
- 2 Early research
- 3 Confounding factors
- 4 The immunological function of the foreskin
- 5 African RCTs
- 6 Real world data
- 7 Studies with contrary conclusions
- 8 Findings
- 9 Follow-up studies
- 10 Real-world
- 11 Problems with promoting circumcision as HIV prevention policy
- 12 Increased risk to women
- 13 Effective prevention
- 14 Population-based studies
- 15 Two African surveys
- 16 See also
- 17 External links
- 18 Abbreviations
- 19 References
Origin of the circumcision/HIV hypothesis
The idea that circumcision prevented HIV transmission was invented by Valiere Alcena, long before there was any "research" to substantiate the claim.[6] In 1986, California urologist Aaron J. Fink, (1926-1994) adopted this idea,[7] and vehemently promoted it,[8] without any kind of proof whatsoever.
In 1986, Fink sent a letter to the New England Journal of Medicine titled "A possible Explanation for Heterosexual Male Infection with AIDS," where he argued that the hard and toughened glans of the circumcised male resisted infection, while the soft and sensitive foreskin and glans mucosa of the intact male were ports of entry.[9] Fink proposed in his letter: "I suspect that men in the United States, who, as compared with those in Africa and elsewhere, have had less acquisition of AIDS, have benefited from the high rate of newborn circumcision in the United States," regardless of the fact that the United States has one of the highest circumcision rates, and one of the highest HIV rates, in the western (industrialized) world (compare with European countries, Canda, and Australia).[10]
Fink's proposal appeared in media throughout the US and Canada. Asked about his idea by a United Press reporter, Fink replied "This is nothing I can prove."[11] This didn't stop other physicians from conducting "research" leading to a steady stream of widely publicized articles arguing that circumcised men were less likely to contract HIV - with the result that prevention of HIV infection has now surpassed even cancer prevention as the most popular claim of circumcision advocates.
“ | Fink's Own Words This is nothing I can prove. – Aaron J. Fink ("This Little Operation". Marked in Your Flesh. p.206-208) |
Alcena and Fink lacked a hypothesis to explain why the foreskin would be an entry point for HIV infection, but this was supplied by circumcision promoter Gerald N. Weiss and two colleagues. Weiss et al. (1993) produced the plausible but incorrect hypothesis that Langerhans cells attracted HIV. A medical journal in Israel was willing to publish the paper by Weiss et al.[12].
Fink abandoned the circumcision/HIV controversy in 1991, and he died in 1994. He left behind an indelible legacy nonetheless; the circumcision/HIV hypothesis continues to be supported by researchers and scientists that are adopting his assertions and writing studies based upon them, and the campaign to establish a causal link between HIV infection and the presence of the foreskin continues to this day.
Early research
Hrdy (1987) identified numerous African cultural practices other than circumcision or non-circumcision that would contribute to the spread of HIV infection. Such factors include:
- Female circumcision and infibulation.
- Promiscuity.
- Homosexuality and anal intercourse.
- Practices resulting in exposure to blood.
- Practices involving the use of shared instruments.
- Contact with non-human primates.[13]
Carael et al. (1988) studied HIV transmission among heterosexual couples in Central Africa. No difference was found between couples in which the male was circumcised and in which the male was intact.[14]
de Vincenzi & Mertens (1994) reviewed the literature regarding the alleged role of the foreskin in HIV transmission. They concluded:
The potential public-health benefits of male circumcision have been greatly discussed in the past 50 years, often in a passionate and emotional manner. However, relatively few studies have been carried out and those that have, present conflicting results. The major criticism of most of the studies preformed to date is the lack of attention given to potential confounding factors, which could be related to both circumcision status and risk of sexually transmitted infections, such as sexual behaviour or differences in hygienic practices, or differential use of specific health facilities. As Poland [48] noted, "We must remember that circumcision is not performed randomly."
Therefore, further efforts are still required to quantify the relative risk associated with the lack of male circumcision. Some of this can be achieved by using observational designs which better address the limitations discussed above. Laboratory and primate research might also continue to provide useful information.
As the safety, expected benefits, feasibility and acceptability of mass circumcision are all questionable, neither public-health interventions nor intervention studies appear to be defensible options before there is stronger evidence from observational studies in different settings that show lack of male circumcision may be a genuinely independent risk factor for the transmission of HIV.[15]
Darby (2002) examined the claims that circumcision is preventive of infection with HIV. He tabulated the prevalence of circumcision and HIV infection in various nations. He found no connection between the prevalence of circumcision and HIV infection. Darby also compared the nineteenth century British attempts to control syphilis (then a dreaded and incurable disease) with male circumcision, which was equally unsuccessful.[16]
Thomas et al. (2004) studied the incidence of HIV in circumcised and intact men in a United States Navy population. A slightly higher incidence of HIV infection was found in circumcised men (84.9%) as compared with intact men (81.8%). The authors concluded:
Although there may be other medical or cultural reasons for male circumcision, it is not associated with HIV or STI prevention in this U.S. military population.[17]
Confounding factors
Debunked ad-hoc hypotheses
Various hypotheses have been suggested in regards to the mechanism whereby circumcision prevents the tarnsmission of HIV. They have all been disproven, however, and all of the "studies" attempting to establish a causal link between circumcion and HIV transmission remain unsubstantiated by a working hypothesis.
Keratinization hypothesis
Perhaps the oldest hypothesis on the mechanism whereby circumcision prevents the transmission of HIV is the theory that suggests that the keratinized surface of the penis in circumcised male resists infection, while the mucosa of the glans and inner of the intact male are ports of entry, which was purported by Aaron J. Fink.
Recent studies, however, disprove this hypothesis. One study found that there is "no difference between the keratinization of the inner and outer aspects of the adult male foreskin," and that "keratin layers alone were unlikely to explain why uncircumcised men are at higher risk for HIV infection."[18] Another study found that "no difference can be clearly visualized between the inner and outer foreskin."
Langerhans cell hypothesis
Recent circumcision studies in Africa were conducted under the hypothesis that the Langerhans cells were the prime port of entry for the HIV virus. According to the hypothesis, circumcision was supposed to prevent HIV transmission by removing the Langerhans cells found in the inner mucosal lining of the foreskin.
deWitte found that not only are Langerhans cells found all over the body and that their complete removal is virtually impossible, but furthermore, deWitte found that Langerhans cells that are present in the foreskin produce Langerin, a substance that has been proven to kill the HIV virus on contact, acting as a natural barrier to HIV-1 transmission by Langerhans cells.[19]
Bacterial environment hypothesis
This hypothesis attempts to identify the change in bacterial environment that results in the penis as a result of adult circumcision, as the mechanism whereby circumcision reduces the spread of HIV transmission. A desperate ad-hoc hypothesis, the explanation is rather farfetched. The argument is that the change in bacterial environment after circumcision makes it difficult for bacteria that cause diseases to live; there are less chances for penile inflammation, a condition that facilitates the transmission of viruses. The chances for penile inflammation are reduced, thereby reducing the chances of sexually transmitted viruses, such as HIV.[20]
Presenting this hypothesis presents a two-fold problem. First, it presents an irrelevant conclusion; the discredited randomized control trials were measuring frequency in HIV transmission, not for frequency in penile bacterial inflammation, and whether said inflammation facilitated sexually transmitted HIV. And secondly, circumcision advocates give themselves the new burden of proving the newly introduced hypothesis, that change in bacterial infection does indeed result in a significant reduction of HIV transmission. A new study is needed to measure HIV transmission in men who have been circumcised, intact men with constant penile inflammations, and intact men who don't suffer constant penile inflammation. Unless the randomized controlled studies were limited to only intact men who suffered constant penile inflammation.
The immunological function of the foreskin
The foreskin's inner fold and the glans of the penis are comprised of mucous membrane tissue. These are also present in your eyes, mouth, and all other bodily orifices including the female genitals. These are the first line of immunological defense for the body's orifices. These mucous membranes perform many immunological and hygienic functions.
Certain components such as Langerhans cells,[21] plasma cells,[22] apocrine glands,[23] and sebaceous glands,[24][25][26][27], collectively secrete emollient lubricants.[28] Apocrine glands perform a crucial function by secreting enzymes such as lysosomal enzymes, cathepsin B, chymotrypsin, and neutrophil elastase.[29]
There is also some research to suggest that lysozyme may protect against HIV infection.[30] [31]
Apocrine glands also produce cytokine,[32] which is a very important non-antibody protein that generates immune response when in contact with specific agents. Plasma cells which increase in number in response to pathogens levels, secrete immunoglobulin.[22] It is also very important to note that Langerhans cells that are present in the foreskin produce Langerin, a substance that has been proven to kill human immunodeficency virus (HIV) on contact.[33]
All of these function to sequester and “digest” foreign pathogens. All these substances play an important role in protecting the penis from viral and bacterial pathogens. The immunological functions of the human prepuce have been extensively documented by respected researchers for quite some time.[31]
Circumcision destroys the natural immunological protections of the foreskin and preputial sac, so it results in increased risk of contracting infection.
African RCTs
Strong bias exists in the RCTs.[34][35][36][37][38] "These trials, designed to detect a minimum 50 percent reduction in HIV risk, should provide definitive evidence regarding the efficacy and safety of MC within three to five years."[39] By designing a trial to "detect" a minimum 50 percent reduction risk in HIV, these researchers might have artificially created the clinical setting to observe the effect they were looking to discover.
Boyle & Hill (2011) have shown these RCTs to be have significant methodological flaws and statistical errors that render their claims invalid. Although a 60 percent relative reduction in HIV was claimed, the absolute reduction was a statistically insignificant 1.3 percent.[40]
Concerns about the three randomized controlled clinical trials (RCCTs) in Africa (in South Africa, Uganda, and Kenya)[41][42][43]:
- The three RCTs were terminated early because results had reached a signifıcent level showing reduced HIV infections in experimental compared with control groups; however, it was too soon to gauge long-term effectiveness.
- The results have no relevance for women or for men who have sex with men.
- Far more participants were lost to follow-up than were reported to have contracted HIV.
- A substantial number of participants appeared to have contracted HIV from nonsexual sources: 23 of the 69 infections reported in the South African trial and 16 of the 67 in the Ugandan study.[44]
- Participants received continuous counseling, free condoms, and monitoring for infection, which was unlikely in real-world campaigns.
- The sanitary conditions of the surgeries would be diffıcult to replicate on a mass scale in many parts of Africa where HIV infection rates and prevalence are highest.[45][46]
- Follow-up of any of these RCCTs is impossible. Study participants agreed to be circumcised when joining the study and were randomized into “circumcise now” and “circumcise later” groups.[47]
Real world data
Countries in Africa
According to demographic health studies performed in other countries in Africa, HIV transmission was prevalent in circumcised men in at least 6 different countries:
Cameroon
In Cameroon, where 91% of the male population is circumcised, the ratio of [[circumcised[[ men vs. intact men who contracted HIV was 4.1 vs. 1.1. [48]
Ghana
In Ghana, the ratio is 1.6 vs 1.4 (95.3% circumcised). "...the vast majority of Ghanaian men (95 percent) are circumcised... There is little difference in the HIV prevalence by circumcision status..."[49]
Lesotho
In Lesotho, the ratio is 22.8 vs 15.2 (23% circumcised). "The relationship between male circumcision and HIV levels in Lesotho does not conform to the expected pattern of higher rates among uncircumcised men than circumcised men. The HIV rate is in fact substantially higher among circumcised men (23 percent) than among men who are not circumcised (15 percent). Moreover, the pattern of higher infection rates among circumcised men compared with uncircumcised men is virtually uniform across the various subgroups for which results are shown in the table. This finding could be explained by the Lesotho custom to conduct male circumcision later in life, when the individuals have already been exposed to the risk of HIV infection. (Additional analysis is necessary to better understand the unexpected pattern in Table 12.9.)"[50]
- An interesting defense of male circumcision, given the fact that the latest "studies," if they can even be called that, observed HIV transmission in men circumcised as adults. Then again, this demographic health survey was conducted in 2004, BEFORE the newer "studies" in 2006. None the less, the unproven assertion that "circumcision is only effective in reducing the risk of HIV when done in infancy" persists in some circles.
Malawi
DHS 2004 - 13.2 vs 9.5 (20% circumcised)
- "The relationship between HIV prevalence and circumcision status is not in the expected
direction. In Malawi, circumcised men have a slightly higher HIV infection rate than men who were not circumcised (13 percent compared with 10 percent). In Malawi, the majority of men are not circumcised (80 percent).[51]
- ...where one would expect HIV to be the most rampant.
Rwanda
DHS 2005 - 3.8 vs 2.1 [52]
South Africa
Rosenberg et al. (2018) report that circumcised men in South Africa are more likely to be HIV infected than intact men.[53]
Swaziland
DHS 2006-2007 - 22 vs 20
- "As Table 14.10 shows, the relationship between HIV prevalence and circumcision status is not in the expected direction. Circumcised men have a slightly higher HIV infection rate than men who are not circumcised (22 percent compared with 20 percent).[54]
Zambia
The prevalence of HIV infection among men aged 15-29 has not decreased despite several campaigns to perform male circumcision.
Garenne & Matthews (2019) report:
In a multivariate analysis, based on the 2013 DHS survey, circumcised men were found to have the same level of infection as uncircumcised men, after controlling for age, sexual behaviour and socioeconomic status. Lastly, circumcised men tended to have somewhat riskier sexual behaviour than uncircumcised men. This study, based on large representative samples of the Zambian population, questions the current strategy of mass circumcision campaigns in southern and eastern Africa.[55]
Malaysia
According to Malaysian AIDS Council vice-president Datuk Zaman Khan, more than 70% of the 87,710 HIV/AIDS sufferers in the country are Muslims. In Malaysia, most, if not all Muslim men are circumcised, whereas circumcision is uncommon in the non-Muslim community. 60% of the Malaysian population is Muslim, which means that HIV is spreading in the community where most men are circumcised at an even faster rate, than in the community where most men are intact.<ref [<title> parameter missing!. Retrieved 15 June 2022.></ref>
Interestingly enough, Malaysia is home to the TARA KLamp, a controversial circumcision device being marketed in KwaZulu Natal, Africa in the name of HIV prevention.
Philippines
Tuli or male circumcision, a nearly compulsory cultural practice in the Philippine Islands, causes 93 percent of Filipino males to be circumcised. In the 2010 Global AIDS report released by UNAIDS in late November, the Philippines was one of seven nations in the world which reported over 25 percent in new HIV infections between 2001 and 2009, whereas other countries have either stabilized or shown significant declines in the rate of new infections. Among all countries in Asia, only the Philippines and Bangladesh are reporting increases in HIV cases, with others either stable or decreasing. [56]
The statistics suggest that removal of the protective foreskin by circumcision increases the risk of contracting HIV infection.
Israel
Despite circumcision being near-universal, HIV is an increasing problem in Israel.[57][58][59][60]
The United States
In America, the majority of the male population is circumcised, approximately 62%,[61] while in most countries in Europe, circumcision is uncommon. One would expect for there to be a lower transmission rates in the United States, and for HIV to be rampant in Europe; HIV transmission rates are in fact higher in the United States, where most men are circumcised, than in various countries in Europe, where most men are intact.[62]
A common explanation given for this difference is the fact that sex education and instruction in the proper use of condoms is better executed in Europe than in the United States, where sex education is poor.
However, it is precisely these reasons given, that sex education and condoms aren't catching on in Africa, why circumcision advocates say "mass circumcision campaigns" should be promoted in Africa. What failed in the United States is somehow supposed to work miracles in Africa.
Studies with contrary conclusions
According to USAID, there appears no clear pattern of association between male circumcision and HIV prevalence—in 8 of 18 countries with data, HIV prevalence is lower among circumcised men, while in the remaining 10 countries it is higher.[63]
"Conclusions: We find a protective effect of circumcision in only one of the eight countries for which there are nationally-representative HIV seroprevalence data. The results are important in considering the development of circumcision-focused interventions within AIDS prevention programs."[64]
Results: ...No consistent relationship between male circumcision and HIV risk was observed in most countries."[65]
Findings
Male circumcision has been found not to decrease the risk of HIV and may in fact increase the risk of male to female transmission[66][67][68][69][70]
Follow-up studies
Using a population-based survey, Westercamp et al. (2010) examined the behaviors, beliefs, and HIV/HSV-2 serostatus of men and women in the traditionally non-circumcising community of Kisumu, Kenya prior to establishment of voluntary medical male circumcision services. A total of 749 men and 906 women participated. Circumcision status was not associated with HIV/HSV-2 infection nor increased high risk sexual behaviors. In males, preference for being or becoming circumcised was associated with inconsistent condom use and increased lifetime number of sexual partners. Preference for circumcision was increased with the belief that circumcised men are less likely to become infected with HIV.[71]
Real-world
An analysis of HIV prevalence compared to circumcision status in sub-Saharan Africa concluded that male circumcision is not associated with reduced HIV prevalence.[72] Another study on circumcision prevalence compared to HIV in the general South African population concluded: “Circumcision had no protective effect on HIV transmission.”[73] When commercial sex worker patterns are controlled, male circumcision is not signifıcantly associated with lower HIV prevalence.[74] Mathematical impact modeling of circumcision, antiretroviral therapy (ART), and condom use for South Africa concluded: “Male circumcision was found to have considerably lower impact than condom use or anti-retroviral therapy on HIV infection rates and death rates.”[75] Both the U.S. and sub-Saharan Africa have relatively high incidence rates of HIV infection, considering that about 75% of U.S. men and about 70% of sub-Saharan African men are circumcised—higher percentages than in most other regions or countries with lower prevalence of HIV.[76]
There is no clear pattern of association between male circumcision and HIV prevalence. In 10 out of 18 countries, HIV prevalence is higher amongst circumcised men.[77] Furthermore, HIV prevalence was found to be higher amongst circumcised males and females for virgins and adolescents in Kenya, Lesotho, and Tanzania.[78]
David Gisselquist, Ph.D.[a 1], who has studied health care practices in sub-Saharan Africa, finds that much of health care, especially injection practices, in Africa is non-sterile, and is likely the cause of the high incidence of HIV infection. He notes that the consensus to make sex the primary cause of infection was determined in the 1980s and is likely to be inaccurate, because it does not give sufficient weight to medical transmission of HIV infection.[79] Gisselquist et al. argue strongly that statistical evidence indicates that 5/6s of the HIV infection in Africa is non-sexual.[80][81] Male circumcision has been proposed to reduce the incidence of sexual transmission of HIV. In reality, it actually increases the sexual transmission of HIV. Even if it did work, it would be ineffective against non-sexual transmission by unsafe health care. Furthermore, non-sterile health care could mean that the circumcision operation could transmit the HIV infection to the patient.[82]
Problems with promoting circumcision as HIV prevention policy
The fact that the World Health Organization is corrupt is now well-established:
Circumcision advocates use the discredited RCT African studies and WHO's endorsement based on them as proof "beyond reasonable doubt" that circumcision "reduces the risk of HIV." However, there are problems with the WHO's endorsement, as the studies on which it is based on suffer various flaws and confounding factors that bring their credibility in to question, many of which will be discussed in this article.
On their website, the WHO acknowledges that, "[m]ale circumcision provides only partial protection," and that it should be part of a "comprehensive HIV prevention package" that includes HIV testing and counseling services, treatment for STD infections, the promotion of safer sex practices and the provision of condoms and the promotion of their correct and consistent use.
Van Howe & Boyle (2018) pointed out numerous reasons that one should doubt the published results of the randomised clinical trials (RCTs)[83]
George C. Denniston, M.D.[a 2], M.P.H.[a 3], the president of Doctors Opposing Circumcision (D.O.C.), in a letter to Ambassador Deborah L. Birx, M.D.[a 2], M.P.H.[a 3], (2020), the head of the President’s Emergency Plan for AIDS Relief (PEPFAR) has called on PEPFAR to suspend the provision of male circumcision because it is ineffective and may increase the reception of HIV infection due to the loss of immunological protections of the foreskin, and to focus on the provision of anti-retroviral therapy and condoms.[84]
Fish et al. (2020), speaking for the VMMC Experience Project, published an article that described the PEPFAR program to circumcise African men, as racist and neo-colonialist.[85]
Threre now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.
Increased risk to women
A recent prospective study[86] showed that male circumcision offered no protection to women, and an RCCT[87] found that male circumcision actually increased the risk to women. Women also are placed at greater risk from unsafe sex practices when they, or their circumcised male partners, wrongly believe that with circumcision they are immune to HIV and therefore they choose not to use condoms.[88][89]
There are legitimate additional concerns about:
- How male circumcision programs, or being circumcised, will influence human behavior.
- The sidelining of women when considering male circumcision as a prevention method.
- The tendency of both men and women to ascribe undue power to a technical fıx for what must remain a matter of human control, as in the use of condoms and other safe sex practices.[76]
Effective prevention
Exposure Route | Estimated infections per 10,000 exposures to an infected source | |||
---|---|---|---|---|
Blood Transfusion | 9,000[91] | |||
Childbirth (to child) | 2,500[92] | |||
Needle-sharing injection drug use | 67[93] | |||
Percutaneous needle stick | 30[94] | |||
Receptive anal intercourse* | 50[95][96] | |||
Insertive anal intercourse* | 6.5[95][96] | |||
Receptive penile-vaginal intercourse* | 10[95][96][97] | |||
Insertive penile-vaginal intercourse* | 5[95][96] | |||
Receptive oral intercourse*§ | 1[96] | |||
Insertive oral intercourse*§ | 0.5[96] | |||
* assuming no condom use § source refers to oral intercourse performed on a man |
The three main transmission routes of HIV are sexual contact, exposure to infected body fluids or tissues, and from mother to fetus or child during perinatal period. It is possible to find HIV in the saliva, tears, and urine of infected individuals, but there are no recorded cases of infection by these secretions, and the risk of infection is negligible.[98] Anti-retroviral treatment (ART) of infected patients also significantly reduces their ability to transmit HIV to others, by reducing the amount of virus in their bodily fluids to undetectable levels.[99] [84]
Population-based studies
September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:
- Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[100]
- Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[101]
No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.
Two African surveys
The previously reported studies were from developed Western nations. Now we have information from Sub_Saharan Africa.
French scientist Michel Garenne, Ph.D. has published two reports in 2022 comparing the incidence of HIV infection in circumcised and intact men.
In his first report, Garenne presented the findings from a study in Lesotho, the enclave in South Africa. He reported:
In couple studies, the effect of circumcision and VMMC on HIV was not significant, with similar transmission from female to male and male to female. The study questions the amount of effort and money spent on VMMC in Lesotho.[102]
In his second report, Garenne (2022) presented information from six Sub-Saharan African nations (Eswatini, Lesotho, Malawi, Namibia, Zambia, Zimbabwe). He reported:
"Results matched earlier observations made in South Africa that circumcised and intact men had similar levels of HIV infection."[103]
See also
- Foreskin
- Immunological and protective function of the foreskin
- PEPFAR
- Preputial sac
- World Health Organization
- Bill & Melinda Gates Foundation
External links
- Milos, Marilyn (September 2007).
Answers To Your Questions About Circumcision and HIV/AIDS
, NOCIRC. Retrieved 7 December 2019. - (2016).
HIV/AIDS
, Doctors Opposing Circumcision (D.O.C.). Retrieved 11 June 2020. -
The VMMC Experience Project
. Retrieved 7 March 2021. - Foregen Staff (8 March 2021).
International Contractors are Profiteering from New Circumcision Devices
, Foregen. Retrieved 8 March 2021.
Abbreviations
- ↑
Doctor of Philosophy
, Wikipedia. Retrieved 16 June 2021. (Also abbreviated as D.Phil.) - ↑ a b
Doctor of Medicine
, Wikipedia. Retrieved 14 June 2021. In the United Kingdom, Ireland and some Commonwealth countries, the abbreviation MD is common. - ↑ a b
Master of Public Health or Master of Philosophy in Public Health
, Wikipedia. Retrieved 14 June 2021.
References
- ↑ (2007).
Male circumcision for HIV prevention
, World Health Organization. Retrieved 6 May 2011. - ↑ Mazzotta, Meredith (4 March 2011)."Swaziland embarks on ambitious plan to circumcise 80 percent of men 18 to 49 this year". Retrieved 6 May 2011.
Quote:The emphasis is on reaching 80 percent coverage with the Soka Uncobe campaign...
- ↑ (February 2008).
Male Circumcision and Risk for HIV Transmission and Other Health Conditions: Implications for the United States
. Retrieved 1 June 2011. - ↑ (March 2007).
Success Stories: Male Circumcision: A Question and Answer Session
, CDC. Retrieved 1 June 2011. - ↑ (9 January 2011).
Funding
. Retrieved 1 June 2011. - ↑ Alcena V. AIDS in Third World Countries. N Y State J Med. October 2006; 8: 446. PMID. DOI. Retrieved 28 May 2020.
- ↑ Glick LB (2005):
"This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy
, in: Marked in Your Flesh. New York, NY: Oxford University Press. P. 206. ISBN 0-19-517674-X. Retrieved 19 February 2011.
Quote:What if circumcision protected against infection with HIV...
- ↑ Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. October 2000; 14(15): 2361-2370. PMID. DOI.
- ↑ Fink AJ. A possible Explanation for Heterosexual Male Infection with AIDS. New England Journal of Medicine. 315(18): 1167. PMID.
- ↑ WHO/UNAIDS (2004).
A global view of HIV infection
, World Health Organization. Retrieved 27 February 2011. - ↑ Glick LB (2005):
"This Little Operation", Jewish American Physicians and Twentieth-Century Circumcision Advocacy
, in: Marked in Your Flesh. New York, NY: Oxford University Press. P. 207. ISBN 0-19-517674-X. Retrieved 19 February 2011.
Quote:This is nothing I can prove.
- ↑ Weiss GN, Sanders M, Westbrook KC. The distribution and density of Langerhans cells in the human prepuce: site of a diminished immune response?. Isr J Med Sci. January 1993; 20(1): 42-3. PMID. Retrieved 28 October 2022.
- ↑ Hrdy DB. Cultural practices contributing to the transmission of human immunodeficiency virus in Africa. Rev Infect Dis. November 1987; 9(6): 1109-19. PMID. DOI. Retrieved 12 May 2021.
- ↑ Carael M, Van de Perre PH, LePage PH, Allen S, et al. Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS. June 1988; 2(3): 201-5. PMID. Retrieved 28 May 2020.
- ↑ de Vincenzi I, Mertens T. Male circumcision: a role in HIV prevention?. AIDS. 1994; 8(2): 153-60. PMID. Retrieved 29 May 2020.
- ↑ Darby R. Been There, Done That: Thoughts on the proposition that yet more circumcision can save the world from AIDS. Australian Quarterly. September 2002; 74(5): 26-35. Retrieved 8 May 2021.
- ↑ Thomas AG, Bakhireva LN, Brodine SK, Shaffer RA. Prevalence of male circumcision and its association with HIV and sexually transmitted infections in a U.S. Navy population. Abstract no. TuPeC4861. Presented at the XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004.
- ↑ Dinh MH, McRaven MD, Kelley Z, Penugonda S, Hope TJ. Keratinization of the adult male foreskin and implications for male circumcision. AIDS. 27 March 2010; 24(6): 899-906. PMID. Retrieved 28 June 2011.
Quote:We found no difference between the keratinization of the inner and outer aspects of the adult male foreskin. Keratin layers alone are unlikely to explain why uncircumcised men are at higher risk for HIV infection.
- ↑ de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MAWP, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek TBH. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells . Nature Medicine. 4 March 2007; 13(3): 367-71. PMID. PMC. DOI. Retrieved 6 October 2022.
- ↑ Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, Bowers J, Ravel J, Keim PS, Serwadda D, et al. The Effects of Circumcision on the Penis Microbiome. PLoS ONE. 2010; 5(1) DOI. Retrieved 29 June 2011.
Quote:The anoxic microenvironment of the subpreputial space may support pro-inflammatory anaerobes that can activate Langerhans cells to present HIV to CD4 cells in draining lymph nodes. Thus, the reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases.
- ↑ Weiss GN, Sanders M, Westbrook KC. The distribution and density of Langerhans cells in the human prepuce: site of diminished immune response?. Isr J Med Sci. January 1993; 29(1): 42-43. Retrieved 20 October 2019.
- ↑ a b Flower PJ, Ladds PW, Thomas AD, Watson DL. An immunopathologic study on the bovine prepuce. Vet Pathol. March 1983; 20(2): 189-201. Retrieved 20 October 2019.
- ↑ Ahmed A, Jones AW. Apocrine Cystadenoma: a report of two cases occurring on the prepuce. Br J Dermatol. December 1969; 81(12): 899-901. Retrieved 20 October 2019.
- ↑ Hyman AB, Brownstein MH. Tyson's "glands": ectopic sebaceous glands and papillomatosis penis. Arch Dermatol. January 1969; 99(1): 31-36. Retrieved 20 October 2019.
- ↑ Delbanco E. Über das gehäufte Auftreten von freien Talgdrüsen an der Innenfläche des Präputiums [About the increased occurrence of free sebaceous glands on the inner surface of the prepuce] (German). Monatshefte für praktische Dermatologie. 1904; 38: 536-538. Retrieved 20 October 2019.
- ↑ Piccinno R, Carrel CF, Menni S, et al. sebacous glands mimicking molluscum contagiosum. Acta Derm Venerol. 1990; 70: 344-345.
- ↑ Krompecher S. Die Histologie der Absonderung des Smegma praeputii [Histology of allocation of a smegma praeputii] (German). Anatomischer Anzeiger. 1932; 75: 170-176.
- ↑ Parkash S, Jeykumar S, Subramanyan K, Chaudhuri S. Human subpreputial collection: its nature and formation. J Urol. August 1973; 110(2): 211-212. Retrieved 20 October 2019.
- ↑ Frohlich E, Shamburg-Lever G, Klesses C. Immunelectron microscopic localization of cathepsin B in human apocrine glands. J Cutan Pathol. February 1993; 20(1): 54-60.
- ↑ Hill, George (7 September 2003).
Summary of evidence that the foreskin and lysozyme may protect against HIV infection
. Retrieved 20 October 2019. - ↑ a b Fleiss P, Hodges F, Van Howe RS. Immunological functions of the human prepuce. Sex Trans Infect. October 1998; 74(5): 364-67. PMID. PMC. DOI. Retrieved 14 January 2022.
- ↑ Ahmed AA, Nordlind K, Schultzberd M, Liden S. Immunohistochemical localization of IL-1 alpha-, IL-1 beta-, IL-6- and TNF-alpha-like immunoreactivities in human apocrine glands. Arch Dermatol Res. 1995; 287(8): 764-766. Retrieved 20 October 2019.
- ↑ de Witte L, Nabatov A, Pion M, et al. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med. March 2007; 13(3): 367-371. Retrieved 20 October 2019.
- ↑ Green LW, et al. Male circumcision is not the HIV 'vaccine' we have been waiting for! . Future HIV Ther. 2008; 2(3): 193–199.
- ↑ Montori VM, Devereaux PJ, Adhikari NKJ, et al. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005; 294: 2203-2209.
- ↑ Ioannidis JP. Contradicted and initially stronger effects in highly cited clinical research . JAMA. 2005; 294: 218-228.
- ↑ Wheatley K, Clayton D. Be skeptical about unexpected large apparent treatment effects: the case of an MRC AML12 randomization. Control Clin Trials. 2003; 24: 66-70.
- ↑ Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med. 2004; 350: 1143-1147.
- ↑ Program and Policy Implications For HIV Prevention and Reproductive Health , Contribution:
Male Circumcision: Current Epidemiological and Field Evidence
, USAID. (January 2002). Retrieved 29 September 2019.
Quote:designed to detect a minimum 50 percent reduction in HIV risk
- ↑ Boyle GJ, Hill G. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns . Thompson Reuter. December 2011; 19(2): 316-34. PMID. Retrieved 30 December 2020.
- ↑ Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial. PLoS Med. 25 October 2005; 2(11): e298. Retrieved 31 December 2021.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. Lancet. 24 February 2007; 369(9562): 643–56. PMID. DOI. Retrieved 31 December 2021.
- ↑ Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet. 24 February 2007; 369(9562): 657-66. PMID. DOI. Retrieved 31 December 2021.
- ↑ Gisselquist D (2008):
7
, in: Points to consider: responses to HIV/AIDS in Africa, Asia, and the Caribbean. London: Adonis and Abbey. - ↑ Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000; 14: 2361–2370.
- ↑ Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision — a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005; 5: 165–173.
- ↑ Slutsky AS, Lavery JV. Data safety and monitoring boards. N Engl J Med. 2004; 350: 1143-1147.
- ↑ Mosoko JJ, Affana GAN (2005):
16
, in: Prévalence du VIH et facteurs associés. Calverton, MD, USA (ed.). Edition: Enquête Démographique et de Santé du Cameroun. Cameroon: DHS. P. 309. Retrieved 2 June 2011.
Quote:Contrairement aux résultats trouvés dans d’autres pays, notamment le Kenya...
- ↑ Marum L, Muttunga J, Munene F (Central Bureau of Statistics):
13
, in: HIV Prevalence and Associated Factors. Work: Kenya: Demographic and Health Survey 2003. Nairobi, Kenya: Central Bureau of Statistics. Pp. 250-251.
Quote:...the vast majority of Ghanaian men (95 percent) are circumcised... There is little difference in the HIV prevalence by circumcision status...
- ↑ (2005) HIV Prevalence and Associated Factors. Work: Lesotho Demographic and Health Survey 2004. Calverton, Maryland: Ministry of Health and Social Welfare. P. 13. Retrieved 2 June 2011.
- ↑ Chipeta J, Schouten E, Aberle-Grasse J (2005):
12
, in: HIV Prevalence and Associated Factors. Work: Malawi Demographic and Health Survey 2004. Calverton, Maryland: National Statistical Office. P. 234. Retrieved 2 June 2011. - ↑ http://www.measuredhs.com/pubs/pdf/FR183/15Chapter15.pdf p. 10
- ↑ Rosenberg MS, Gómez-Olivé FX, Ronr JK, Kahn K, Bärnighausen TW. Are circumcised men safer sex partners? Findings from the HAALSI cohort in rural South Africa. PLOS ONE. 1 August 2018; 13(8): e0201445. PMID. PMC. DOI. Retrieved 20 October 2019.
- ↑ (2006).
Swaziland Demographic and Health Survey
. Retrieved 15 June 2022. - ↑ Garenne M, Matthews A. Voluntary medical male circumcision and HIV in Zambia: expectations and observations. J Biosoc Sci. 14 October 2019; Epub ahead of print: 1-13. PMID. DOI. Retrieved 19 October 2019.
- ↑ http://globalnation.inquirer.net/news/breakingnews/view/20110102-312124/Philippines-HIVAIDS-problem-worries-UN
- ↑ (4 July 2008).
Failing the AIDS Test
. Retrieved 5 January 2020. - ↑ (9 July 2008).
Israeli Gays Shun Condoms Despite Worrying Rise in AIDS
. Retrieved 5 January 2020. - ↑ (30 November 2008).
Has the AIDS Cocktail Worked Too Well in Israel?
. Retrieved 5 January 2020. - ↑ (27 June 2008).
HIV Diagnoses in Israel Climb; New Cases Among Gays Up Sharply
. Retrieved 5 January 2020. - ↑ Moore, Peter (3 February 2015).
Young Americans less supportive of circumcision at birth
. Retrieved 15 June 2022. - ↑ http://data.unaids.org/pub/Report/1998/19981125_global_epidemic_report_en.pdf
- ↑ http://www.measuredhs.com/pubs/pdf/CR22/CR22.pdf
- ↑ http://www.iasociety.org/Default.aspx?pageId=11&abstractId=2197431
- ↑ "http://apha.confex.com/apha/134am/techprogram/paper_136814.htm
- ↑ Castilho, E.A., with: Boshi-Pinto C., Guimaraes M.D.G.: Male circumcision and HIV heterosexual transmission (2002) XIV World AIDS Conference.
- ↑ Guimaraes MD, Vlahov D, Castilho EA. Postcoital vaginal bleeding as a risk factor for transmission of the human immunodeficiency virus in a heterosexual partner study in Brazil (Rio de Janeiro Heterosexual Study Group). Arch Intern Med.. 1997; 157(12): 1362-1368.
- ↑ Guimaraes, M., with: Castilho E., Ramos-Filho C., et al.: Heterosexual transmission of HIV-1: a multicenter study in Rio de Janeiro, Brazil (1991) VII Intl Conf on AIDS.
- ↑ Changedia, S.M., with: Gilada I.S.: Role of male circumcision in HIV transmission insignificant in Conjugal relationship (2002) XIV World AIDS Conference.
- ↑ (6 March 2007).
Circumcision protects men from AIDS but might increase risk to women, early results suggest
, International Herald Tribune. - ↑ Westercamp M, Bailey RC, Bukusi EA, Montandon M, Kwena Z, et al. Male Circumcision in the General Population of Kisumu, Kenya: Beliefs about Protection, Risk Behaviors, HIV, and STIs. PLoS ONE. 2010; 5(12) DOI.
- ↑ Garenne M. Long-term population effects of male circumcision in generalized HIV epidemics in sub-Saharan Africa . Afr J AIDS Res. 2008; 7(1): 1-8.
- ↑ Connolly C, Simbayi LC, Shanmugam R, Nqeketo A. Male circumcision and its relationship to HIV infection in South Africa: results of a national survey in 2002 . S Afr Med J. 2008; 98: 789-794.
- ↑ Talbott JR. Size matters: the number of prostitutes and the global HIV/AIDS pandemic. PloS One. 2007; 2(6): e543.
- ↑ Lima, V., with: Anema A., Wood R., et al.: The combined impact of male circumcision, condom use and HAART coverage on the HIV-1 epidemic in South Africa: a mathematical model, Cape Town. (2009) 5th IAS Conference on HIV Treatment, Pathogenesis and Prevention (abstract WECA105).
- ↑ a b Green LW, Travis JW, McAllister RG, Peterson KW, Vardanyan AN, Craig A. (Department of Epidemiology and Biostatistics, University of California at San Francisco, USA) Male circumcision and HIV prevention insufficient evidence and neglected external validity . Am J Prev Med. November 2010; 39(5): 479-482. PMID.
- ↑ DHS Comparative Reports 22, Contribution:
Levels and spread of HIV seroprevalence and associated factors: Evidence from national household surveys
, Measre DHS. Retrieved 29 September 2019. - ↑ Brewer DD, Potterat JJ, Roberts Jr JM, Brody S. Male and Female Circumcision Associated With Prevalent HIV Infection in Virgins and Adolescents in Kenya, Lesotho, and Tanzania . Annals of Epidemiology. 17(3): 217.e1-217.e12. Retrieved 2 June 2011.
- ↑ Gisselquist D, Rothenberg R, Potterat J, Drucker E. Non-sexual transmission of HIV has been overlooked in developing countries. Br Med J. 2002; 324(7331): 235.
- ↑ Gisselquist D, Potterat JJ. Heterosexual transmission of HIV in Africa: an empiric estimate . Int J STD AIDS. 2003; 14: 162-73.
- ↑ Gisselquist D, Potterat JJ, Brody S. Running on empty: sexual co-factors are insufficient to fuel Africa's turbocharged HIV epidemic . Int J STD AIDS. 2004; 15(7): 442-52.
- ↑ Nyindo M. Complementary factors contributing to the rapid spread of HIV-I in sub-Saharan Africa: a review. East African Medical Journal. 2005; 82(1): 40-46.
- ↑ Van Howe RS, Boyle GJ. Meta-analysis of HIV-acquisition studies incomplete and unstable. BJU Int. 31 October 2018; Retrieved 5 September 2020.
Quote:Given the effectiveness of condoms, the lack of consistent findings on national levels, the methodologically flawed RCTs, the lack of translational research, and the impressive potential uptake and effectiveness of pre-exposure prophylaxis, circumcision as an intervention to prevent HIV infection should be treated with greater scepticism.
- ↑ a b Denniston, George C.: World Health Organization, HIV, and male circumcision, Doctors Opposing Circumcision (D.O.C.). (29 June 2020). Retrieved 2 September 2020.
- ↑ Fish, Max, Shavisi, Arianne, Gwaambuka, Tatenda, Tangwa, Godfrey B., Ncayiyana, Daniel, Earp, Brian D. A new Tuskegee? Unethical human experimentation and Western neocolonialism in the mass circumcision of African men. Developing World Bioeth. 9 September 2020; 00: 1-16. PMID. Retrieved 7 April 2021.
- ↑ Turner AN, Morrison CS, Padian NS, et al. Men’s circumcision status and women’s risk of HIV acquisition in Zimbabwe and Uganda. AIDS. 2007; 21: 1779–1789.
- ↑ Wawer MJ, Makumbi F, Kigozi G, et al. Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet. 2009; : 229-237.
- ↑ Nyakairu, F. (13 August 2008).
Uganda turns to mass circumcision in AIDS fıght
, Reuters Africa. - ↑ (July 2008).
Circumcision gives men an excuse not to use condoms
, The New Humanitarian (formerly IRIN News), UN Offıce for the Coordination of Humanitarian Affairs. Retrieved 5 January 2020. - ↑ Smith DK, Grohskopf LA, Black RJ, et al. Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States. MMWR. 2005; 54(RR02): 1-20. Retrieved 31 March 2009.
- ↑ Donegan E, Stuart M, Niland JC, et al. Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations. Ann. Intern. Med.. 1990; 113(10): 733-739. PMID.
- ↑ Coovadia H. Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS. N. Engl. J. Med.. 2004; 351(3): 289-292. PMID. DOI.
- ↑ Kaplan EH, Heimer R. HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.. 1995; 10(2): 175-176. PMID.
- ↑ Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview. Am J Med. 1997; 102(5B): 9-15. PMID. DOI.
- ↑ a b c d European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. BMJ. 304(6830): 809-813. PMID. PMC. DOI.
- ↑ a b c d e f Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis. 2002; 29(1): 38-43. PMID.
- ↑ Leynaert B, Downs AM, de Vincenzi I. Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV. Am J Epidemiol. 1998; 148(1): 88-96. PMID.
- ↑
Facts about AIDS & HIV
, avert.org. Retrieved 30 November 2007. - ↑ NPR.org
- ↑ Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
Quote:We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
- ↑ Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
- ↑ Garenne M. Changing relationships between HIV prevalence and circumcision in Lesotho. J Biosoc Sci. 4 April 2022; online ahead of print: 1-16. PMID. DOI. Retrieved 28 October 2022.
- ↑ Garenne M. Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa. J Biosoc Sci. 26 October 2022; : 1-13. PMID. DOI. Retrieved 27 October 2022.